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African elephants (Loxodonta africana) are considered priority species within conservation 
areas because of their aesthetic value, ecological importance, and economic contribution to the 
ecotourism industry. Conservation efforts have focused on protecting habitat, but there are few 
studies investigating the role of disease. The recent discovery of tuberculosis (TB) in a free-
ranging African elephant in Kruger National Park (KNP), South Africa, has resulted in 
movement restrictions, preventing the translocation of elephants from this population. Since 
diagnostic tests for TB in wildlife are limited, the development of blood-based tests to detect 
Mycobacterium tuberculosis complex (MTBC) infection in African elephants is needed. These 
antigen-specific immune assays would have a significant beneficial impact on current practices 
in wildlife and zoological medicine. Therefore, the aim of this project was to identify blood-
based host biomarkers that can be used to detect immune responses of African elephants. 
Cytokine gene expression assays (GEAs) have been employed to measure cell-mediated 
immune responses in a variety of species. These GEAs use real-time, reverse-transcription 
quantitative PCR (RT-qPCR) to measure changes in gene expression of immune cells, 
following stimulation of whole blood. In this study, whole blood from African elephants from 
KNP, a Mycobacterium bovis-endemic area, was stimulated using pokeweed mitogen and 
mycobacterial antigens. Newly designed primers, as well as modified primers originally 
developed for use in other species, were used to amplify and sequence African elephant mRNA 
transcripts of selected target (CXCL9, CXCL10, IFNγ, IL4, IL10, IL12, TGFβ, and TNF) and 
reference genes (ACTB, B2M, GAPDH, YWHAZ). These mRNA transcripts were used to design 
sequence specific primers and develop a RT-qPCR to determine changes in cytokine 
expression as a measure of general immune activation and antigen-specific responses. 
Confirmed mRNA transcripts for African elephants were used to develop real-time RT-
qPCRs for IL10, TNF, and TGFβ, relative to GAPDH as the optimal reference gene. These 
cytokine GEAs demonstrated the use of identified biomarkers to measure immune responses 
in this species. To our knowledge, this was the first study that has investigated cytokine 
biomarkers in African elephants using real-time RT-qPCR.  
Results of the cytokine GEAs showed up-regulation of IL10 and TNF, as well as down-
regulation of TGFβ, in response to mitogen stimulation. When expression of these cytokines 
was evaluated in response to mycobacterial antigen stimulation, a significant up-regulation of 




with ESAT6/CFP10, as well as calculated differential PPD response, a very slight down-
regulation of IL10 was observed, as expected in TB uninfected elephants. Similarly, a slight 
down-regulation of TNF and TGFβ was observed following all mycobacterial antigen 
stimulations.  
Findings in this study provide novel insights into the African elephant immune system. The 
generated mRNA transcripts provide a basis for development of immunological assays for TB, 
as well as other diseases. Finally, evaluation of gene expression following antigen stimulation 
provided insight into the use of PPDa, PPDb and ESAT6/CFP10 as stimulants of antigen-
specific TB responses. This will aid in the development of tools to improve disease detection 






Afrika-olifante (Loxodonta africana) word as ŉ prioriteitspesies in bewaringsgebiede 
beskou, vanweë hul estetiese waarde, ekologiese belang en ekonomiese bydrae tot ekotoerisme 
bedrywighede. Bewaringspogings fokus grotendeels op die beskerming van habitat, maar daar 
is 'n slegs n paar studies wat die rol van siektes in hierdie spesie ondersoek. Die onlangse 
ontdekking van tuberkulose (TB) in 'n vrylopende Afrika-olifant in die Krugerwildtuin (KNP), 
Suid-Afrika, het gelei tot bewegingsbeperkings wat die skuif van Afrika-olifante uit hierdie 
bevolking verhinder. Aangesien diagnostiese toetse vir TB in wildsoorte beperk is, is die 
ontwikkeling van 'n bloedtoets om infeksie met Mycobacterium tuberculosis kompleks 
(MTBC) in Afrika-olifante op te spoor nodig. Antigeen-spesifieke immuuntoetse sal 'n 
voordelige impak op die bestaande praktyke in wild- en dierkundige medisyne hê. Die doel van 
hierdie projek was dus om bloedgebaseerde gasheer-biomerkers te identifiseer wat gebruik kan 
word om immuunresponse van Afrika-olifante te meet. 
Sitokien geenuitdrukkings-toetse (GEA’s) is voorheen gebruik om sel-gemedieerde 
immuunresponse in 'n verskeidenheid spesies te meet. Hierdie toetse gebruik ware-tyd, 
omgekeerde-transkripsie kwantitatiewe polimerase kettingreaksie (RT-qPCR) om 
veranderinge in geenuitdrukking in immuunselle, in gestimuleerde volbloed te meet. In hierdie 
studie is volbloed van Afrika-olifante vanuit KNP, ‘n Mycobacterium bovis endemiese area, 
deur middel van ‘n ‘pokeweed’ mitogeen asook mikobakteriële antigene gestimuleer. Nuut 
ontwerpte inleiers, asook gemodifiseerde inleiers wat oorspronklik vir ander spesies ontwerp 
was, is gebruik om mRNA-transkripte van geselekteerde teiken- (CXCL9, CXCL10, IFNγ, IL4, 
IL10, IL12, TGFβ and TNF) en verwysingsgene (ACTB, B2M, GAPDH, YWHAZ) van Afrika-
olifant te amplifiseer en die volgorder te bepaal. Hierdie mRNA-transkripte was toe gebruik 
om spesifieke sitokien inleiers te ontwerp en 'n RT-qPCR te ontwikkel om veranderinge in 
sitokienuitdrukking te bepaal om sodoende algemene immuunaktivering en antigeenspesifieke 
reaksies te meet. 
Bevestigde mRNA-transkripte vir Afrika-olifante is gebruik om ware-tyd RT-qPCR vir 
IL10, TNF en TGFβ te ontwikkel, relatief tot GAPDH as die optimale verwysingsgeen. Hierdie 
sitokien GEAs dui op die moontlike gebruik van die geïdentifiseerde biomerkers om 
immuunresponse in hierdie spesie te meet. Na ons wete was dit die eerste studie wat sitokien-




Resultate van die sitokien-GEA's het ŉ toename in die IL10 en TNF geenuidrukking asook 
ŉ afnameing in TGFβ geenuitdrukking getoon nadat volbloed met mitogeen gestimuleer was. 
Toe die uitdrukking van hierdie sitokiene na mikobakteriële antigeenstimulasie evalueer was, 
het die uitdrukking van IL10 beduident toegeneem na PPDa- en PPDb-stimulasie. Na 
stimulasie met ESAT6/CFP10, sowel as berekende differensiële PPD-response, is afwaartse 
regulering van IL10 egter waargeneem, in onbesmette olifante. Net so is afname in TNF en 
TGFβ geenuitdrukking waargeneem na aanleiding van mikobakteriële antigeensimulasies. 
Bevindings in hierdie studie bied nuwe insigte tot die immuunsisteem van die Afrika-olifant. 
Die gegenereerde mRNA-transkripte bied 'n basis vir die ontwikkeling van immunologiese 
toetse, nie net vir TB nie, maar ook vir ander siektes. Laastens bied hierdie ondersoek in 
geenuitdrukking na antigeenstimulasie insig oor die gebruik van PPDa, PPDb en 
ESAT6/CFP10 as aanduiders van antigeenspesifieke TB-reaksies. Dit sal help met die 
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Chapter 1: General Introduction 
 
1.1. Background 
1.1.1. African elephants 
African elephants (Loxodonta africana) are listed as vulnerable on the International Union 
for Conservation of Nature’s (IUCN) Red List of Threatened Species (Blanc, 2008). This is 
due to factors such as ongoing poaching and illegal hunting (Schlossberg, Chase and Sutcliffe, 
2019). Other factors that contribute to declining African elephant populations include habitat 
reduction and fragmentation (Sach et al., 2019), which lead to increased human-animal conflict 
(Mmbaga, Munishi and Treydte, 2017; de Sales, Anastácio and Pereira, 2020). While research 
and conservation efforts have focused primarily on habitat protection (Branco et al., 2019; Sach 
et al., 2019), there is still a knowledge gap relating to the role of infectious diseases, such as 
elephant endotheliotropic herpesviruses (EEHV) and tuberculosis (TB), in African elephant 
populations (Maslow and Mikota, 2015; Bronson et al., 2017; Abegglen et al., 2018).  
1.1.2. Mycobacterium tuberculosis complex (MTBC) in African elephants  
The Mycobacterium tuberculosis complex (MTBC) consists of various members of closely 
related gram-positive, acid-fast bacteria, which are primarily transmitted via aerosols (Fowler, 
2008; Coscolla and Gagneux, 2014). Of these, Mycobacterium tuberculosis (M. tb) is most 
commonly found in African and Asian elephants (Elephas maximus) (Mikota et al., 2001; 
Miller et al., 2019), with a few cases of Mycobacterium bovis (M. bovis) (Lyashchenko et al., 
2006; Goosen et al., 2020a). Tuberculosis in elephants was identified as an emerging disease 
following the death of several captive Asian elephants in the 1990’s (Mikota et al., 2001) and 
since then, the disease has been found in various managed elephant populations across the 
world (Lewerin et al., 2005; Mikota, 2008; Angkawanish et al., 2010; Verma-Kumar et al., 
2012). Although many of the reported cases have been in captive Asian elephants, TB has also 
been documented in free-ranging Asian elephants in Sri Lanka and India (Perera et al., 2014; 
Chandranaik et al., 2017; Zachariah et al., 2017). In 2013, the first fatal case of TB in a free-
ranging African elephant was discovered in Kenya (Obanda et al., 2013). More recently, a fatal 
case was discovered in an African elephant bull in Kruger National Park (KNP), South Africa 




Tuberculosis in elephants is likely an anthropozoonotic disease (Zachariah et al., 2017; 
Lainé, 2018). An isolate of M. tb from an Asian elephant in Nepal shared a synonymous single 
nucleotide polymorphism (SNP) with the isolate found in two human samples in the region 
(Paudel et al., 2014), indicating possible spillover from a local handler. Elephant-human 
contact is a frequent occurrence in elephants housed in zoos and used as service animals in 
temples and logging camps. Indirect contact may also occur with people that enter protected 
areas and national parks. Thus, disease spillover from humans to elephants is a rising One 
Health concern (Lainé, 2018; Rosen et al., 2018). 
1.1.3. MTBC diagnostics in elephants 
Tuberculosis in elephants is a chronic disease associated with nonspecific clinical signs of 
weight loss, anorexia, weakness, exercise intolerance, and/or abnormal discharge (Mikota et 
al., 2001; Mikota and Maslow, 2011; Paudel and Toshio, 2016). Signs are typically observed 
only with advanced stages of infection, and often TB is only diagnosed at necropsy (Mikota 
and Maslow, 2011; Paudel and Toshio, 2016). Thus, the first step in managing the spread and 
impact of TB in elephants is early detection. Unlike humans, there are limited options available 
for the diagnosis of TB in elephants. Current diagnostic tests for TB in elephants can be 
classified into two categories: direct detection of the MTBC organisms, and indirect detection 
by measuring cell-mediated or humoral immune responses to mycobacterial antigens. Direct 
detection of the MTBC organisms is achieved using mycobacterial culture and polymerase 
chain reaction (PCR) based methods. Indirect detection of MTBC infection, via cell-mediated 
and humoral immune responses, can be done in vivo or in vitro. The most common methods of 
MTBC diagnostics are discussed below.  
1.1.3.1. Mycobacterial culture and PCR 
Mycobacterial culture of respiratory samples, such as trunk wash (TW) and bronchoalveolar 
lavage (BAL) fluid, is currently regarded as the “gold standard” for antemortem TB diagnosis 
in elephants (World Organisation for Animal Health (OIE), 2018). The United States 
Department of Agriculture (USDA) has recommended the triple trunk wash method for annual 
TB screening (Mikota et al., 2001; United States Animal Health Association (USAHA) 
Elephant Tuberculosis Subcommittee, 2010). With this method, trained elephants aspirate 
sterile saline into their trunks and then forcibly expel it, and this fluid is collected into a sterile 
container. In other cases, the trunk is held up by the trainer and sterile saline is poured into the 




days, within a seven-day period, and transported to a laboratory that is equipped for 
mycobacterial culture. Unfortunately, mycobacterial culture of TW samples has certain 
drawbacks. Mycobacterial culture has varying sensitivity, especially since elephants shed 
mycobacteria intermittently (Fowler, 2008; Maslow and Mikota, 2015; Paudel and Toshio, 
2016). Thus, while a positive culture can confirm TB, a negative culture cannot rule out 
infection. Samples are often difficult to collect, as elephants need to be immobilized or trained 
for sample collection. Consecutive sample collection is difficult to achieve in free-ranging 
elephants since it requires repeated immobilizations. Elephants also use their trunks to explore 
their environment and collect food, increasing the likelihood of contamination with 
environmental bacteria (Hermes et al., 2018). Alternative methods of sample collection have 
also been explored. A study by Goosen et al. (2020a) described a modified procedure for 
collecting trunk wash samples from free-ranging African elephants. A single TW sample 
(approximately 250 mL) is collected from each nostril, separately, during immobilization and 
aspirated into a sterile 500 mL collection chamber. In addition, BAL samples, collected using 
a flexible endoscope inserted via the oral cavity of immobilized elephants Goosen et al. 
(2020a), or via the trunk of trained captive elephants (Hermes et al., 2018) have been used as 
alternative methods to collect respiratory samples for mycobacterial culture. 
Mycobacterial culture is a slow and costly procedure which requires processing in a BSL3 
facility, and 6-8 weeks of incubation. Additionally, culture-positive samples require further 
speciation using methods such as region of difference (RD) PCR, 16S rRNA sequencing, and 
spoligotyping to identify mycobacterial strains (Kamerbeek et al., 1997; Leclerc et al., 2000; 
Warren et al., 2006). Two alternative PCR-based methods have been used for the direct 
detection of MTBC organisms in African elephant samples, including the GeneXpert®  
MTB/RIF Ultra Assay (Cepheid, Sunnyvale, CA, USA) that relies on detection of insertion 
elements IS6110 and IS1081, and the VetMAX™ MTBC qPCR kit that detects the insertion 
element IS6110 (Goosen et al., 2020a, 2020b). The advantage of direct PCR is that it provides 






1.1.3.2. Intradermal tuberculin test  
The intradermal tuberculin test is the only in vivo test recommended by the OIE, for the 
detection of TB in cattle (Cousins and Florisson, 2005). The single comparative intradermal 
tuberculin test (SCITT) has been used to detect TB in wildlife species such as African buffaloes 
(Syncerus caffer), African lions (Panthera leo), and common warthogs (Phacochoerus 
africanus) as well as many wildlife species in zoos (Keet et al., 2010; Miller and Lyashchenko, 
2015; Bernitz et al., 2018b; Roos et al., 2018). However, the SCITT has proven to be unreliable 
in pachyderms such as elephants, with a low sensitivity (16.7%) and specificity (72.4%) 
(Mikota et al., 2001), and therefore is not recommended for TB diagnosis in elephants (Miller 
and Lyashchenko, 2015). 
1.1.3.3. Serology 
Various mycobacterial antigens have been identified that elicit antibody responses in the 
host following exposure. The most common antigens used for diagnostics in elephants include 
the lipoproteins MPT70 and MPT83 (MPB70 and MPB83 in M. bovis) and the MTBC-specific 
antigens, early secretory antigenic target 6 kDa (ESAT6) and culture filtrate protein 10 kDa 
(CFP10) (Lyashchenko et al., 2006; Greenwald et al., 2009). Along with mycobacterial culture, 
the USDA has recommended the use of the Dual Path Platform (DPP®) Vet TB Assay for 
Elephants (Chembio Diagnostic Systems, Inc., Medford, NY, USA) as part of annual TB 
surveillance in captive elephants (USAHA Elephant Tuberculosis Subcommittee, 2010). This 
commercially available assay uses a lateral-flow design, to deliver whole blood, serum, or 
plasma to a nitrocellulose strip containing a control line and two test lines that detect MTBC 
antigen-specific IgG antibodies. The first test line contains the antigen MPB83, while the 
second contains the fusion protein ESAT6/CFP10 (Greenwald et al., 2009). The results are 
read using the DPP® optical-reader device or visually, with a visible line at either or both test 
lines considered positive for TB antibodies (Greenwald et al., 2009). 
Elephants develop a strong humoral response to TB, with serodiagnosis sometimes made 
years before there is a positive mycobacterial culture result (Lyashchenko et al., 2006; 
Greenwald et al., 2009). High sensitivity (approaching 100%) and specificity (approaching 
95%) of serological assays have been demonstrated in captive African and Asian elephants 
using the ElephantTB STAT-PAK® and DPP® Vet TB Assay (Greenwald et al., 2009; 
Lyashchenko et al., 2012, 2018). A retrospective study by Kerr et al. (2019) also showed the 




however important to note that a positive serological result does not equate with current 
infection, since detection of antibodies can also indicate immunity to previous infections, or 
cross-reactivity with shared antigens from other pathogens, such as Mycobacterium szulgai 
(Lacasse et al., 2007; Greenwald et al., 2009). Additionally, both false positive and false 
negative results in elephants have been obtained with serological testing (Lacasse et al., 2007; 
Greenwald et al., 2009). 
1.1.3.4. Interferon-γ release assays (IGRAs) 
Cell-mediated immune (CMI) responses are elicited in many species during early infection 
with M. tb or M. bovis (Thoen and Barletta, 2006; Zuniga et al., 2012). These responses can be 
measured in vitro by cytokine protein production, using species-specific enzyme-linked 
immunosorbent assays (ELISAs) after antigen stimulation of whole blood. One of the cytokines 
that has been shown to be important in CMI responses to TB is interferon-gamma (IFNγ) 
(Cavalcanti et al., 2012; Romero-Adrian et al., 2015). Interferon-γ release assays (IGRAs) have 
been used to diagnose TB in humans as well as various animal species including cattle (Bos 
taurus), domestic cats (Felis catus), African buffaloes, wild dogs (Lycaon pictus), white 
rhinoceros (Ceratotherium simum), and black rhinoceros (Diceros bicornis) (Rhodes et al., 
2011; Bass et al., 2013; Pari et al., 2014; Miller and Lyashchenko, 2015; Bernitz et al., 2018a). 
Cytokine release assays such as IGRAs, often require species-specific antibodies, or antibodies 
from a closely related species, with high identity between protein sequences. For example, the 
ruminant Cattletype® IFNγ ELISA (INDICAL, Inc., San Francisco CA, USA) originally 
designed for cattle, has been successfully used to detect African buffalo IFNγ (Bernitz et al., 
2018a). In species where compatible reagents are not commercially available, the development 
and validation of these assays can be expensive and time consuming (Abegglen et al., 2018). 
Three IGRAs have been developed for the diagnosis of TB in elephants, however, whole blood 
from only a single African elephant was available, and validation was performed using Asian 
elephant samples (Angkawanish et al., 2013; Paudel et al., 2016; Songthammanuphap et al., 





1.1.3.5. Cytokine gene expression assays (GEAs) 
As an alternative to cytokine release assays, cytokine gene expression assays (GEAs) have 
been employed to measure antigen-specific CMI responses. These GEAs use real-time, 
reverse-transcription quantitative PCR (RT-qPCR) to measure changes in gene expression of 
immune cells following antigen stimulation of whole blood. The use of real-time RT-qPCR 
provides a rapid and cost-effective method to determine infection status using antemortem 
samples (VanGuilder, Vrana and Freeman, 2008; Derveaux, Vandesompele and Hellemans, 
2010). For the most part, reagents for RT-qPCR are commercially available, while online tools 
facilitate primer design using species-specific cytokine sequences which are relatively 
conserved in mammals (VanGuilder, Vrana and Freeman, 2008; Roos et al., 2019). 
Cytokine GEAs have been used to diagnose mycobacterial infection in various wildlife 
species such as Asian elephants, spotted hyenas (Crocuta crocuta), African lions, and common 
warthogs (Landolfi et al., 2009; Higgitt et al., 2017; Olivier et al., 2017; Roos et al., 2019). 
Landolfi et al. (2009) developed real-time RT-qPCRs for various cytokines involved in 
humoral and cell-mediated immune responses for use in Asian elephants. A follow-up study 
highlighted trends in expression of certain circulating cytokines that differed between TB 
seronegative and seropositive elephants (Landolfi et al., 2010). Finally, the cytokine GEAs 
were used to categorize elephant infection status using antigen stimulated peripheral blood 
mononuclear cell (PBMC) cultures from M. tb positive and negative Asian elephants (Landolfi 
et al., 2014). The high level of sequence identity between Asian and predicted African elephant 
mRNA sequences (generated using computational analysis) further highlights the potential 
utility of cytokine GEAs for the detection of TB in African elephants (Benson et al., 2013). 
1.2. Problem statement 
The recent discovery of TB in a free-ranging African elephant in KNP has resulted in 
movement restrictions imposed by the South African Department of Agriculture, Land Reform 
and Rural Development (DALRRD), preventing the translocation of African elephants from 
this population (Miller et al., 2019). In addition, M. tb infection contributed to the cause of 
death in two captive elephants in the South African National Biodiversity Institute National 
Zoological Gardens (SANBI-NZG) (unpublished data). Due to the ecological and economical 
importance of this species for the to the ecotourism industry in South Africa (Blignaut, de Wit 
and Barnes, 2008; Kerley et al., 2008), investigating the role of TB in African elephants is 




elephants, the development of a blood-based test to detect MTBC infection in African elephants 
using antigen-specific immunoassays would have a significant beneficial impact on current 
practices in wildlife and zoological medicine. 
1.3. Significance and motivation 
The impact of this research will be basic knowledge generation to provide a greater 
understanding of health in African elephants, a valued national asset for South Africa and the 
African continent. Application of immunological and molecular biological techniques will 
produce new information regarding health and disease in these long-lived mammals, which 
may serve as a model for comparative biology to humans and other long-lived species. In 
addition, the biomarkers identified will be useful for further development of diagnostic tools 
for disease detection and surveillance in African elephants, as well as individual health 
assessment and monitoring. This is important for improving welfare and management of 
captive individuals but also for determining the impact of disease in free-ranging populations. 
A crucial component of conservation programs is to ensure that only healthy animals are 
translocated due to the stress on the individual, costs, logistics, and potential outcome of the 
move for the success of the program. Therefore, diagnostic tools which could minimize 
potential disease introduction during translocation of animals between fragmented populations 
is needed. 
Since diagnostic tests for TB in wildlife are limited, especially in elephants, the development 
of a blood-based test to detect infection in individual African elephants and for surveillance in 
populations, using antigen-specific immunoassays, would have a significant impact on current 
practices in wildlife medicine. Providing accurate tools for disease detection to veterinarians, 
wildlife managers, and decision-makers will enhance individual and population management, 





1.4. Aims and Objectives 
Based on the documented reports of TB in African elephants in KNP, antigen-specific 
immunological responses in this population were investigated using whole blood stimulated 
with mycobacterial peptides. The overall goal of this project was to generate new tools for 
assessing responses to TB, an infectious disease that impacts the health of African elephants 
(both free-ranging and captive populations). These tools will improve disease detection and 
diagnosis, as well as advance our understanding of disease pathogenesis and epidemiology for 
overall improvement of welfare and conservation of this species.  
Main Aim: To identify blood-based host biomarkers that can be used to detect immune 
responses of African elephants. 
Aim 1: Develop and optimize a cytokine gene expression assay (GEA) to measure immune 
activation in African elephants, using mitogen stimulated whole blood. 
• Objective 1.1: To amplify full-length African elephant mRNA transcripts for cytokine 
targets identified as potential biomarkers for TB from literature. 
• Objective 1.2: To identify an optimal reference gene using African elephant mitogen 
stimulated whole blood. 
• Objective 1.3: To determine diagnostic cytokine target genes to measure immune 
activation in African elephants. 
• Objective 1.4: To identify optimal incubation time for mitogen stimulation of African 
elephant whole blood to measure target gene expression. 
• Objective 1.5: To identify potential biomarkers of immune activation, using the 
developed cytokine GEA. 
Aim 2: Characterize changes in cytokine gene expression in African elephants using antigen 
stimulated whole blood. 
• Objective 2.1: Determine the differences in gene expression between TB seropositive- 




1.5. Thesis overview 
Chapter 1: General Introduction 
This chapter highlights the significance and potential impact of the study by providing a brief 
background on M. tb, as well as the impact and history of the disease in African elephants. The 
overall research theme is outlined in this chapter, including study aims and objectives.  
Chapter 2: Development of a cytokine gene expression assay for the relative quantification of 
the African elephant (Loxodonta africana) cell-mediated immune responses 
This chapter describes the development of a real-time, reverse-transcription quantitative PCR 
(RT-qPCR) assay for use with RNA extracted from African elephant whole blood. This 
includes the generation of novel, full-length and partial cytokine mRNA transcripts from 
pokeweed mitogen (PWM) stimulated African elephant whole blood. A panel of reference and 
immune mediator target genes was evaluated to identify candidate biomarkers of in vitro 
immune activation in African elephants to advance the understanding of African elephant 
specific immune responses. Four reference genes were evaluated: actin-beta (ACTB), beta-2-
microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ). A panel of 
eight immune mediator target genes was also examined: C-X-C motif chemokine ligands 9 
(CXCL9) and 10 (CXCL10); interleukins 4 (IL4), 10 (IL10) and 12 (IL12); interferon-gamma 
(IFNγ), transforming growth factor beta (TGFβ), and tumor necrosis factor (TNF). The optimal 
reference gene (GAPDH) was identified, as well as three target genes (IL10, TGFβ, and TNF) 
that met the criteria needed to develop a RT-qPCR. This chapter has been published in 
Cytokine, a peer-reviewed journal. 
Chapter 3: Evaluation of mycobacterial antigen stimulated responses in African elephant 
whole blood using cytokine gene expression assays  
In this chapter, whole blood from African elephants (n = 11) were stimulated with 
ESAT6/CFP10, avium purified protein derivative (PPDa) and bovine purified protein 
derivative (PPDb) for 6 hours. The cohort contained ten MTBC uninfected African elephants 
based on serological and mycobacterial culture results, while one elephant was classified as 
MTBC seropositive, but mycobacterial culture negative. Following antigen stimulation, the 




reference gene GAPDH, was used to assess their potential use as biomarkers for TB in 
elephants.  
Chapter 4: General discussion 
This chapter provides a summary of our results and highlights the principle interpretations, 
with a focus on how these relate to the literature. In addition, limitations of the study are 
discussed.  
Chapter 5: General conclusion and future research 
In this chapter, the overall contribution of this study’s findings to the understanding of immune 






Chapter 2: Development of a cytokine gene expression assay for the relative 
quantification of the African elephant (Loxodonta africana) cell-mediated immune 
responses 
This chapter, published in the peer-revied journal Cytokine, describes the development of a 
real-time, reverse-transcription quantitative PCR (RT-qPCR) assay for use with RNA extracted 
from African elephant whole blood. This includes the generation of novel, full-length and 
partial cytokine mRNA transcripts from African elephant whole blood, as well as the 
identification of candidate biomarkers of in vitro immune activation in African elephants.  
 
2.1. Introduction 
African elephants (Loxodonta africana) are listed as vulnerable on the International Union 
for Conservation of Nature (IUCN) Red List of Threatened Species (Blanc, 2008). The main 
threats to elephant conservation are habitat fragmentation (Fowler, 2008) and increased human-
animal conflict (Schlossberg, Chase and Sutcliffe, 2019); however infectious diseases also pose 
a threat and warrant further investigation. Importantly, infectious disease status needs to be 
considered when animals are translocated for conservation purposes (Fowler, 2008). Important 
infections affecting both human-managed and free-ranging Asian (Elephas maximus) and 
African elephant populations include elephant endotheliotropic herpesvirus (EEHV) and 
Mycobacterium tuberculosis (M. tb) (Fowler, 2008; Maslow and Mikota, 2015; Long, Latimer 
and Hayward, 2016). In both infections, the interplay between pathogen and the host immune 
response is an integral component of disease outcome and the focus of continued research to 
better understand pathogenesis. To date, research on immune responses and diseases has 
focused predominantly on Asian elephants, and information on African elephant immunology 
is sparse (Abegglen et al., 2018). 
Many indirect diagnostic tests are based on the host’s immune response (Lyashchenko et 
al., 2012; Clarke et al., 2017; Chileshe et al., 2019; Bernitz et al., 2020a). To use antibody-
based assays for assessment of immune responses in wildlife such as African elephants, 
species-specific reagents are often required and can be expensive and time consuming to 
develop and validate (Abegglen et al., 2018; Songthammanuphap et al., 2020). Therefore, due 
to the relatively conserved gene sequences of cytokines, as well as the ease and cost 
effectiveness of DNA sequencing, cytokine gene expression assays (GEAs) have been used as 




cell-mediated immune (CMI) responses in vitro (Landolfi et al., 2010; Higgitt et al., 2017; 
Olivier et al., 2017; Roos et al., 2019). Cytokine GEAs measure components of CMI responses 
which are initiated during different stages of infection and allow for rapid, blood-based testing 
(Maas, Michel and Rutten, 2013). 
Various candidate cytokine biomarkers such as IFNγ, TNF, and TGFβ have been 
investigated in Asian elephants (Landolfi et al., 2010; Angkawanish et al., 2013; Paudel et al., 
2016; Songthammanuphap et al., 2020). A study done by Landolfi et al. (2010) demonstrated 
the potential use of a cytokine GEA to differentiate between suspect M. tb-infected and 
uninfected Asian elephants. Therefore, the development of cytokine GEAs in African elephants 
may help elucidate host immune responses and enable the development of potential diagnostic 
assays for this species. 
As a first step in detecting CMI responses in African elephants, the aim of this study was to 
develop a GEA to measure cytokine expression (immune activation) in RNA extracted from 
mitogen stimulated whole blood and to determine which cytokines show promise as possible 
biomarkers of immune activation. The basis of a cytokine GEA relies on sequence-specific 
nucleotide primers which are designed using host mRNA transcripts. Since the sequences 
currently available for African elephants are predicted sequences, generated using 
computational analysis, the first objective of this study was to sequence full-length mRNA 
transcripts for selected host reference and target cytokine genes. The second objective was to 
use the confirmed mRNA transcripts to design sequence-specific primers and develop a real-
time, reverse-transcription quantitative PCR (RT-qPCR) assay. The third objective was to 
characterize the temporal gene expression of these cytokines, to determine the optimal 
stimulation time at which to measure immune responses in this species. Finally, this assay was 
then used to identify candidate biomarkers of in vitro non-antigen specific immune activation 





2.2. Materials and Methods 
2.2.1. Animals and sample collection 
Whole blood samples for this study were collected from 28 free-ranging African bull 
elephants from Kruger National Park (KNP), South Africa. All sample collection was done 
opportunistically during routine immobilizations for management or veterinary procedures. 
Briefly, whole blood was collected from the auricular vein into BD Vacutainer® lithium heparin 
tubes (Becton Dickinson, Franklin Lakes, NJ, USA) and transported to the laboratory at room 
temperature within 4-6 hours of collection. Two elephants were classified as young adults ( 
24 years), with 26 individuals classified as adult ( 25 years) at the time of sampling. 
Ethical approval for the sample acquisition and testing of these animals was granted by the 
Stellenbosch University Animal Care and Use Committee (SU-ACU 2018-6308), and South 
African National Parks Animal Care and Use Committee (SANParks Research Agreement 
BUSP1511). Section 20 approval was granted by the South African Department of Agriculture, 
Land Reform and Rural Development (DALRRD) formerly the Department of Agriculture, 
Forestry, and Fisheries (DAFF Section 20: 12/11/1/7/6). 
2.2.2. Whole blood stimulation 
Whole blood stimulation was performed using nil (phosphate buffered saline (PBS)) and 
pokeweed mitogen (PWM) in-tube stimulations prepared as follows: one mL heparinized 
whole blood was transferred into a Vacutainer® tube (BD Biosciences) containing either 10 µl 
PBS (Thermo Fisher Scientific, Waltham, MA, USA) or 10 µl PWM (10 µg/ml final 
concentration in PBS) (Sigma-Aldrich, St. Louis, MO, USA). All whole blood stimulations 
were performed in duplicate; tubes were inverted several times and incubated at 37°C for 6 and 
24 hours. For one component of the study, replicate nil and PWM stimulated whole blood from 
three individuals were incubated for 0, 4, 6, 8, 10, 12, 18 and 24 hours. Following incubation, 
blood was transferred to a 2 mL microcentrifuge tube and centrifuged at 2 000 x g for 15 
minutes. The plasma fraction was harvested, and the remaining cell pellet resuspended in 1 mL 
RNALater® Solution (Ambion, Foster City, CA, USA). Both plasma and cell pellets, stabilized 




2.2.3. RNA extraction and reverse transcription 
The RiboPure™-Blood Kit (Ambion) was used to extract RNA from RNALater® stabilized 
cell pellets, according to the manufacturer’s instructions, with the following modifications: 
RNA elution was performed in two steps. The first elution was performed using 30 µl elution 
buffer, incubated for 5 minutes at room temperature, and centrifuged for 30 seconds at 16 000 
x g. The second elution was performed using 30 µl elution buffer, incubated for 3 minutes, and 
centrifuged for 1 minute at 16 000 x g to obtain a final volume of 60 µl total RNA. The quantity 
(ng) and A260/280 and A260/230 ratios of the extracted RNA were measured using the 
Nanodrop 1000 spectrophotometer (ThermoFisher Scientific), after which RNA was stored at 
-80°C prior to reverse transcription. 
Reverse transcription was performed using QuantiTect® Reverse Transcription Kit (Qiagen, 
Hilden, Germany) according to manufacturer’s instructions. Each reaction contained genomic 
DNA (gDNA) Wipeout Buffer to ensure effective elimination of gDNA from initial RNA 
sample. An estimated total of 200 ng RNA was reverse transcribed to cDNA (total volume 
20μl), after which cDNA was stored at -20°C prior to downstream analysis. 
2.2.4. Primer design 
A panel of potential immune biomarkers was selected for use in African elephants, based 
on previous studies in Asian elephants, spotted hyenas, African lions, and common warthogs 
(Landolfi et al., 2010; Higgitt et al., 2017; Olivier et al., 2017; Roos et al., 2019). Four 
reference genes were selected: actin-beta (ACTB), beta-2-microglobulin (B2M), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ). A panel of 
eight immune mediator target genes were also selected: C-X-C motif chemokine ligands 9 
(CXCL9) and 10 (CXCL10); interleukins 4 (IL4), 10 (IL10) and 12 (IL12); interferon gamma 
(IFNγ), transforming growth factor beta (TGFβ), and tumor necrosis factor (TNF). 
Predicted African elephant mRNA transcripts derived by automated computational analysis 
using gene prediction methods were obtained from NCBI GenBank® genetic sequence database 
(Benson et al., 2013) and the Ensembl Genome Browser (Cunningham et al., 2019). In 
addition, Asian elephant mRNA transcripts for ACTB, GAPDH, TGFβ, IFNγ, TNF, IL10, IL4, 
and IL12 were obtained from the NCBI GenBank® genetic sequence database. For B2M, 
CXCL9, CXCL10, and YWHAZ, Asian elephant mRNA transcripts were not available, and 




sequence database (Benson et al., 2013). Multiple sequence alignments of Asian elephant, 
common warthog, and predicted African elephant mRNA transcripts were performed using 
ClustalX version 2.1 (Larkin et al., 2007). Based on sequence alignments, novel primers were 
designed and used in combination with previously designed Asian elephant primers (J. 
Landolfi, unpublished data). Where differences between African elephants and other species 
were observed, primers were adapted to include ambiguous nucleotides to increase chances of 
amplification. All oligonucleotide primers (Table 2.1) were synthesized by Integrated DNA 




Table 2.1: Primers used for the amplification and sequencing of African elephant mRNA transcripts. 









ACTB F1: AAC GGC TCS GGY ATG TG R1: CAG AGC TTC TCC TTG ATG TCA CG 700 55 MT096344, 
MT096345 F2: AAG TTC GCC ATG GAC GAT GA R2: TCA TAG ATG GGC ACA GTG TG 509 55 
F3: GAC TAC CTC ATG AAG ATC CTC AC R3: GTG TAA CGC AAC TAA AGA CAG TC 596 55 
B2M F1: TTC ACC ATG CGT CTC TTC GT R1: TGA AAA CTC ACC CCA TTT CAC TAC  366 55 MT096346, 
MT096347, 
MT096348 
CXCL9 F1: ATC CCA CCA CTA TGA AGA AAA GTG  R1: GTA AAG TGT TGT CTT ACG CAG TC 405 55 MT096349, 
MT096350 
CXCL10 F1: TCT CAG CAC CAT GGA CCA ACG T R1: TAC AGT TAT CAT GCT TCT CTC TGC  333 55 MT096351, 
MT096352 
GAPDH F1: AAG ATY GTC AGC AAT GCY TCC R1: CCA GGA AAT GAG CTT GAC AAA 500 55 MT096353, 
MT096354 F2: GGA CTT CCT GGA GAT AGC AAA AT R2: CAT TGC TGA CAA TCT TGA GAG AGT  553 55 
F3: TAC ACT GAA GAC CAG GTT GTC TC R3: GAA ACT GTA GAG GAT GGG AGA TTC  306 55 
IFNγ F1: GAT CAA CTT TAC ACA GGA GCT ACT  R1: TGA CCA TTA TTC TGA TGC TCT CC 567 55 MT096355, 
MT096356 
IL4 F1: ATG GGT CTC ACC TAC CAG CTG R1: CAC TTG GAG TAT TTC TCC TTC ATG 
ATC 
400 58 MT096357 
IL10 F1: TCA ACC TAT GTA TAA AAG GGG GAC  R1: GTC TAG TAG AGT CGC CAT GTT G 675 55 MT096358, 
MT096359 




Table 2.1 (Continued) 
 









IL12 F1: CAG CCA CCG CCC TCA C R1: TGT GGC ACA GTC TCA CTG TTG A 500 55 MT096360, 
MT096361 F2: GCA CTT CTG AAG AGA TTG ACC ATG R2: AGA ATT ACG GTG CCA GCT TAA GTA 562 55 
TGFβ F1: CGC GTG CTA ATG GTG GAA A R1: GTG TCC AGG CTC CAR ATG TAG G 600 55 MT096362, 
MT096363 F2: GTG GAA ATC AAA GGG CTG AAT AAC  R2: TCC TCT CTC CAC CTT TAA TGG G 600 55 
TNF F1: CTC TCC AAA GGA CAC CAT GAG C R1: ATG GGC ATC CAT TCC CCC TCA  742 55 MT096364, 
MT096365 
YWHAZ F1: AAC ATC CAG TCA TGG ATA AAA A R1: CTA CTG TGT AAA TTT CAG AAT  796 55 MT096366, 
MT096367 




2.2.5. PCR amplification and mRNA sequence confirmation 
The PCR reactions to amplify mRNA transcripts were performed using 1 µl of cDNA in a 
25 µl PCR reaction containing 12.5 μl of OneTaq® Hot Start 2X Master Mix with Standard 
Buffer (New England Biolabs Inc, Ipswich, MA, USA), 0.5 μl of each primer (10 μM) and 10.5 
μl nuclease-free water. The PCR cycling conditions, using a Veriti® Thermal Cycler (Applied 
Biosystems, Foster City, CA, USA), were as follows: initialization at 94°C for 2 minutes, 
followed by 45 cycles of denaturation at 94°C for 30 seconds, annealing and elongation at 55°C 
for 30 seconds (58°C for IL4; Table 2.1), and extension at 68°C for 1 minute. Final extension 
was done at 68°C for 10 minutes. Negative (no template) controls were included in all PCR 
reactions. To confirm that cDNA was amplified and not gDNA carried over from the RNA 
extraction, PCR was performed using the following templates: extracted RNA only; extracted 
RNA treated with gDNA Wipeout Buffer (without reverse transcription); and extracted RNA 
treated with gDNA Wipeout Buffer and reverse transcribed to cDNA, as described in section 
2.2.3. 
Amplicon sizes were estimated following electrophoresis using a 1.5% agarose gel (Lonza 
Group, Basel, Switzerland). For each cytokine, sequences from two randomly selected 
elephants were determined and used for further analyses. Where sequences could not be 
confirmed in the initial two elephants, cDNA from a third animal was used to obtain sequences 
for some cytokines. 
The PCR products from the selected African elephants were sent for post PCR clean-up and 
sequencing at the Stellenbosch University Central Analytical Facility (CAF; Stellenbosch, 
South Africa) using the ABI 3730XL 96-capillary DNA Analyzer (Applied Biosystems), 
according to the manufacturer’s guidelines. Sequences were edited and aligned using the 
Sequencher® version 5.1 DNA sequence analysis software (Gene Codes Corporation, Ann 
Arbor, MI, USA; http://www.genecodes.com) as well as the Geneious® 6.0.6 software 
(Biomatters Ltd., Auckland, New Zealand; http://www.genious.com). Sequences were then 
authenticated using the NCBI Basic Local Alignment Search Tool (BLAST) software program 
(Altschuk et al., 1990). Newly generated mRNA transcripts derived from this study were 






2.2.6. qPCR design 
Novel qPCR primers were designed using the confirmed African elephant mRNA transcript 
sequences. Primers for four reference genes: ACTB, B2M, GAPDH and YWHAZ; and eight 
target genes: CXCL9, CXCL10, IFNγ, IL4, IL10, IL12, TGFβ and TNF were synthesized by 
Integrated DNA Technologies (IDT Inc.) (Table 2.2). 
To determine the suitability of qPCR primers, cDNA from five randomly selected African 
elephants was amplified using both conventional PCR and qPCR. Conventional PCR was 
performed as described in section 2.2.5, with the following PCR cycling conditions: 
initialization at 94°C for 2 minutes, followed by 45 cycles of denaturation at 94°C for 30 
seconds, annealing and elongation at 60°C for 30 seconds and extension at 68°C for 1 minute. 
Finally, extension was performed at 68°C for 10 minutes. Negative (no template) controls were 
included in all PCR reactions. Amplicon sizes were estimated following electrophoresis using 
a 1.5% agarose gel, and PCR products were sent for post PCR clean-up and sequencing at CAF. 
Sequences were edited and aligned using the Sequencher 5.1 software and authenticated using 
the NCBI BLAST software program.  
To confirm amplification using qPCR, cDNA from the two African elephants, used for PCR 
amplification and sequencing, was run on the CFX96 Touch™ Real-Time PCR Detection 
System (Bio-Rad Laboratories, Hercules, CA, USA). Each gene target was amplified 
separately in a 10 µl PCR reaction containing 1 µl of cDNA, 5 µl iTAQ™ Universal SYBR® 
Green Supermix (Bio-Rad), 0.4 μl of each forward and reverse primer (final concentration of 
400 nM), and nuclease-free water. The qPCR cycling conditions were as follows: polymerase 
activation at 95°C for 30 seconds, followed by 40 cycles of denaturation at 95°C for 5 seconds, 
and annealing and elongation at 60°C for 30 seconds. Melt-curve analysis was performed over 
a 65–95°C range with increased increments of 0.5°C every 5 seconds. The melt curve of each 





2.2.7. Selection of reference and target genes 
The amplification efficiencies of both reference and target genes were determined using 
five-fold serial dilutions which were prepared as follows: RNA was extracted from PWM 
stimulated whole blood from three African elephants and an estimated total of 1000 ng RNA 
was reverse transcribed for each elephant as described in section 2.6. The cDNA was then 
pooled, and a serial dilution prepared (1:5, 1:25, 1:125, 1:625, 1:3125, 1:15625), with an 
estimated range of 1000 to 0.064 ng. Each dilution point was run in triplicate using the qPCR 
cycling conditions described above, and amplification efficiencies were determined as 
previously described (Livak and Schmittgen, 2001). Reference and target genes with RT-qPCR 
efficiencies of 90-110% were selected for further analysis. To validate the use of the relative 
quantification method described in (Livak and Schmittgen, 2001), the amplification 
efficiencies of all reference gene RT-qPCRs were compared to those of the target genes to 
evaluate compatibility. The final subset of target genes was chosen as those that had 
amplification RT-qPCR efficiencies within the recommended range, and were compatible with 
an efficient, stable reference gene. 
Relative expression stability for each reference gene was determined using RNA extracted 
from nil and PWM stimulated whole blood of three African elephants. A total of 200 ng of 
RNA was reverse transcribed into 20 μl cDNA, and 1 μl cDNA was amplified using the RT-
qPCR as described in section 2.2.3. The amplification stability of each reference gene was then 
determined using the geNorm applet in Microsoft Excel (Vandesompele et al., 2002) and the 
NormFinder Excel Add-In (Andersen, Jensen and Ørntoft, 2004). The coefficient of variance 
was calculated using triplicate reactions to determine the intra-assay variability (IAV). 
2.2.8. Proof of concept for using GEA to detect immune activation 
To determine the utility of the GEA to measure cytokine expression in mitogen stimulated 
samples (as an indication of immune activation), the relative abundance of the target genes was 
measured over a 24-hour incubation period in three African elephants. Cytokine expression 
was measured at time points 0, 4, 6, 8, 10, 12, 18 and 24 hours, to determine the optimal 
stimulation time. Following initial temporal results, cytokine expression was measured for 16 
African elephants, with nil and PWM stimulation samples at both 6 and 24 hours. For all 
samples, RNA was extracted, 200 ng of RNA reverse transcribed to 20 μl cDNA, where after 





2.2.9. Data analysis 
The relative fold change (2−ΔΔCq) was used to measure up-regulation of the target genes in 
response to mitogen stimulation (Livak and Schmittgen, 2001). Relative gene expression of the 
target genes was normalized to a selected reference gene that is continuously expressed. For 
each stimulation (nil and mitogen), the mean reference gene Cq value was subtracted from the 
mean target gene Cq to determine the relative abundance of the target gene mRNA (∆Cq). The 
∆Cq derived from the nil tube was then subtracted from that of the mitogen tube (∆∆Cq). 
Thereafter, the relative fold change in abundance of the target transcript (2−ΔΔCq) was measured 
and calculated as previously described (Livak and Schmittgen, 2001). Up-regulation was 
classified as a minimum fold change (2−ΔΔCq) of > 1 while fold change <1 was classified as 
down-regulation (Radonic et al., 2004; Schmittgen and Livak, 2008). A paired Student’s t-test 
was used to compare mitogen expression at 6 and 24 hours. A p-value < 0.05 was considered 
statistically significant. Statistical analyses were performed using GraphPad Prism version 5.00 
for Windows (GraphPad Software, La Jolla, CA, USA; www.graphpad.com). The Spearman 
Rank correlation coefficient was calculated using Excel software (Microsoft Excel version 






Blood samples opportunistically obtained from 28 African elephants were used in this study. 
The extracted RNA yield from the 28 African elephant whole blood samples ranged from 92 
to 4076 ng (median: 1258 ng). The A260/280 ratio ranged from 1.7 to 2.1 (median: 2.0) and 
the A260/230 ratio ranged from 0.1 to 8.6 (median: 2.1). Where A280/A260 and A260/230 
ratios were outside the recommended range, samples were still used for further analysis due to 
the limited availability of samples for this species. Using conventional PCR, full coding 
sequences, determined using the NCBI BLAST CDS predictor, were obtained for CXCL9, 
CXCL10, IFNγ, IL4, IL12, and YWHAZ; and partial coding sequences were obtained for ACTB, 
B2M, GAPDH, and TNF. One full and one partial coding sequence for both IL10 and TGFβ 
were obtained (Table 2.1). High nucleotide sequence identity was observed when mRNA 
sequences generated from African elephant whole blood, during this study, were compared to 
published Asian elephant (96.6-99.8%) and common warthog sequences (72-97.6%). 
The suitability of newly designed qPCR primers (Table 2.2), designed using African 
elephant mRNA transcripts (NCBI GenBank® Accession numbers MT096344-M096367; 
Table 2.1), was confirmed for all four reference genes (ACTB, B2M, GAPDH, and YWHAZ) 
and five out of the eight target genes (IL4, IL10, IL12, TGFβ, and TNF), following the 
successful amplification and sequence confirmation of mRNA transcripts from mitogen 
stimulated African elephant whole blood samples. Amplification of CXCL9, CXCL10 and IFNγ 
using RT-qPCR was unsuccessful and these genes were subsequently excluded from further 
analysis. Using the characteristic melt curve peaks at each dilution point to confirm the 
amplification of each gene, the RT-qPCR amplification efficiencies were calculated for four 
reference (ACTB, B2M, GAPDH, and YWHAZ) and four target (IL4, IL10, TGFβ, and TNF) 
genes, and fell within the recommended range of 90-110% (Table 2.2, Appendix Figures 1 and 
2) (Livak & Schmittgen, 2001; Pfaffl, 2001) while the amplification efficiency of IL12 was 
above 110% and therefore excluded from downstream analysis. The intra-assay variability for 
all genes was below 5%.  
Using nil and PWM stimulated whole blood samples, B2M and GAPDH were identified as 
the most stably expressed reference genes (Appendix Figure 3). When comparing the reference 
gene amplification efficiencies with that of the target genes to assess compatibility, GAPDH 




and was chosen as the optimal reference gene. Subsequently, IL4 was excluded from 
downstream analysis as it was not compatible with any of the reference genes.   
The mitogen-induced expression of IL10, TNF, and TGFβ was measured over time in 
samples from three African elephants. Both IL10 and TNF showed up-regulation over time 
(Figure 2.1A and B). For IL10, the highest median fold change was observed at 0, 6, and 24 
hours of stimulation. For TNF, the highest median fold change was observed at 0, 6, and 18 
hours of stimulation. Expression of TGFβ was considered down-regulated as median fold 





Table 2.2: African elephant qPCR primer sequences and assay parameters determined during the development of the gene expression assay, 
including the derivative melt curve peak (DM), amplification efficiency (E), R2 and the intra-assay variability (IAV). 




E (%) R2 IAV 
(%) 
ACTB ACCCTGTGTTGCTGACTGAG CAGAGGCATACAGGGACAGC 135 84 109.1 0.999 1.4 
B2M GCTTGCTCCAAAGGTTCAGG GGTGGATGAAACCCAGACACA 93 78 102.6 0.998 0.7 
GAPDH ACGTGTCAGTGGTGGATCTG GCCTGCTTCACCACCTTCTT 79 78.5 104.7 0.999 0.9 
YWHAZ ACTACCGTTACTTGGCTGAGG CTGATAGGATGCGTTGGTTGC 127 79 96.4 0.977 0.9 
IL4 CAGGTCTCTAAACGCCACGA CCAGGTTTGTCATGCTGCTG 79 78 99.6 0.995 1.6 
IL10 CGGTGGAGCAAGTGAAGGAA TGTCAAACTCACTCATGGCC 75 77.5 96.3 0.998 1.9 
IL12 GGCCAGACAAACCCTAGAGT CCAGGCAATTCTCATTCGCG 131 79 143.6 0.993 2.0 
TGFb TCCACCGAGAAGAACTGCTG GCTCCAGATGTAAGGGCAGG 132 85 99.1 0.997 1.1 
TNF CCTGTAGCACACGTTGTAGC CATCGGAAGGCACCATCAGC 127 82 101.7 0.999 1.0 







Figure 2.1: Gene expression of IL10 (A), TNF (B), and TGFβ (C) measured in three African 
elephants over 24 hours following pokeweed mitogen (PWM) stimulation. The median 
expression at each time point is indicated by a solid horizontal line. The dotted line on the y-












Samples from 16 African elephants were available for 6- and 24-hour stimulation time 
points. The median fold change for IL10 was measured as 16.9 and 18.5, at 6 and 24 hours, 
respectively (Figure 2.2A), indicating up-regulation at both time points. No significant 
difference was seen between the two time points. For TNF, median fold change was 2.1 and 
8.1, at 6 and 24 hours, respectively (Figure 2.2B). However, at the 6-hour time point, 3 of the 
16 samples had a fold change for TNF that was < 1, with median fold change significantly 
higher at 24 hours (p = 0.0035). For TGFβ, median fold change was 0.5 and 1, at 6 and 24 
hours, respectively (Figure 2.2C), indicating down-regulation of this gene at the 6-hour time 
point. Mitogen stimulation thus did not result in the up-regulation of TGFβ, and there was no 
significant difference between the time points. 
The distribution of cytokine responses shown in Figure 2A and 2B appeared to have some 
separation into high and low expressors, especially for IL10 and TNF at 24 hours stimulation. 
When individual elephant values were compared, of the 8 elephants that had IL10 fold changes 
greater than the median at 24 hours, only 4 of these animals also had TNF fold changes greater 
than the median. The Spearman rank correlation coefficient (Rs) was -0.0147, which indicates 
essentially no correlation between IL10 and TNF fold change values for individual elephants. 
A similar coefficient (Rs = 0.0147) was calculated for the association between TNF and TGFβ, 






Figure 2.2: Gene expression of IL10 (A), TNF (B) and TGFβ (C) measured in 16 African 
elephants measured at 6 and 24 hours, following pokeweed mitogen (PWM) stimulation. The 
median fold change for each group is indicated by a solid horizontal bar. The dotted line on the 
y-axis indicates the minimum fold change (2−ΔΔCq >1) for expression to be considered up-





Cell-mediated immune responses in elephants have not been well characterized. Since 
immunoassays are often based on detecting and measuring changes in cytokines, and can be 
the basis for diagnostic tests, the aim of this study was to identify biomarkers and develop a 
cytokine GEA for use with whole blood samples in African elephants. The findings presented 
included the first report of full coding sequences for the reference gene YWHAZ, and immune 
mediator target genes (CXCL9, CXCL10, IFNγ, IL4 and IL12), as well as partial coding 
sequences for ACTB, B2M, GAPDH and TNF, and one full and one partial coding sequence for 
both IL10 and TGFβ.  These confirmed African elephant sequences provided the basis for 
developing real-time RT-qPCR assays. Future studies should consider sequencing additional 
animals to confirm these sequences in a larger cohort of African elephants. 
Using the newly confirmed coding sequences, an African elephant cytokine GEA was 
developed. Of the reference and target genes evaluated, GAPDH was identified as the most 
stable and efficiently expressed reference gene and was compatible with three cytokine target 
genes (IL10, TGFβ, and TNF). Similarly, in a real-time RT-PCR, validated for Asian elephants, 
GAPDH was also identified as the best reference gene and cytokines IL10, TGFβ, and TNF 
could be detected in RNA extracted from unstimulated blood samples, albeit at low levels 
(Landolfi et al., 2010). Despite low level amplification of IL4 and IL12 in Asian elephants 
(Landolfi et al., 2010), and the use of African elephant specific qPCR primers, we were unable 
to develop an assay for these markers. This was due to the lack of compatibility between 
GAPDH and IL4, out of range RT-qPCR amplification efficiency of IL12, and the lack of 
consistent amplification of CXCL9, CXCL10, and IFNγ, which precluded their use in the 
cytokine GEA. Attempts at PCR temperature optimization was unsuccessful using the current 
primers designed for these genes, and further studies are needed to optimize qPCR primers and 
reaction conditions for these targets in African elephants. 
Mitogen stimulation of whole blood is expected to result in general immune activation, 
detected by changes in relative abundance of cytokines measured in GEAs, which can be used 
as a proof of concept (positive control) for antigen-specific cytokine GEAs. A time point series 
of stimulated whole blood samples was used to identify optimal incubation times for detection 
of the three target cytokine genes. The median expression of IL10 showed a cyclic pattern over 
the 24-hour period, with up-regulation highest at 0, 6 and 24 hours, while the expression 




over time, and TGFβ showing slight down-regulation. Although there was variation in the 
patterns of expression between the three African elephants tested, the median up-regulation of 
all three cytokines at 0 hours suggests that activation of circulating immune cells had occurred 
prior to experimental stimulation. A possible explanation might be that immune activation 
occurred within the 15 minutes that the stimulated whole blood was centrifuged for separation 
before they were stored at -20°C. Since the elephants had been herded by a helicopter during 
induction of immobilization, this may have resulted in release of catecholamines, which have 
been shown to induce both pro-inflammatory and anti-inflammatory responses in macrophages 
(Barnes, Carson and Nair, 2015; Shaw et al., 2018). Furthermore, glucocorticoids (GCs) 
produced as part of the physiological stress response may have resulted in the down-regulation 
of inflammatory mediators, including TNF, and decreased the stability of the cytokine mRNA, 
effects which are typically seen several hours after GCs are produced (Reichardt et al., 2001; 
Anderson et al., 2004). These two factors may have resulted in the biphasic response observed 
during the temporal component of our study. However, we did not test for the presence of 
catecholomines or GCs in our samples and no definitive conclusions can be drawn regarding 
their presence. Therefore, further studies using African elephants trained for blood collection 
should be performed to determine the impact of capture and immobilization on cytokine gene 
expression. 
In this study, GEAs for cytokines TNF, TGFβ, and IL10 were developed to further facilitate 
research on immune responses in African elephants. Tumor necrosis factor forms part of the 
acute phase response and is produced by activated macrophages/monocytes, lymphocytes, and 
natural killer (NK) cells (Wang, Czura and Tracey, 2003). This cytokine plays an important 
role in mediating cellular responses, including enhanced natural killing cell function, induction 
of apoptosis in mature T-cells, and neutrophil activation (Rath and Aggarwal, 1999; Wang, 
Czura and Tracey, 2003; Abbas, Lichtman and Pillai, 2016). A study by Landolfi et al. (2010), 
using RNA extracted from unstimulated blood samples, showed that Asian elephants, 
suspected to be infected with M. tb, had significantly higher expression of TNF than uninfected 
elephants. In this study, TNF was up-regulated in mitogen stimulated whole blood of African 
elephants at both 6 and 24 hours, with significantly higher expression at 24 hours. These 
findings support further investigation of TNF to evaluate the diagnostic potential of this 
cytokine in infections and inflammation in African elephants as seen in Asian elephants. 
Gene expression of two anti-inflammatory cytokines (IL10 and TGFβ) was also examined 




pathogens, limits immunopathology and plays a role in wound healing (Sabat et al., 2010; 
Saraiva, Vieira and O’Garra, 2019). Previous studies have shown that increased expression of 
IL10 promotes disease progression during M. tb infection (Beamer et al., 2008), while IL10 
knockout mice showed increased immune-related pathology (Higgins et al., 2009). In this 
study, IL10 expression was up-regulated at 6 and 24 hours, following mitogen stimulation of 
African elephant whole blood. The relatively high level of up-regulation may be related to the 
nonspecific expression of IL10 by a wide range of cell types (including almost all leukocytes) 
(Sabat et al., 2010; Saraiva, Vieira and O’Garra, 2019). Mitogen stimulation results in the 
general activation of circulating immune cells, resulting in the increased expression of IL10 in 
examined peripheral blood samples. Based on its crucial role as a mediator of inflammation in 
a variety of diseases, and detection of up-regulation in this study, IL10 should be included in 
further studies on immune responses in African elephants. 
Transforming growth factor beta also has anti-inflammatory properties and is involved in 
regulatory activities including T-cell suppression and macrophage activation (Toossi and 
Ellner, 1998; Travis and Sheppard, 2014). However, expression of TGFβ may also promote 
inflammation under certain conditions (Sanjabi et al., 2009). In contrast to TNF and IL10, slight 
down-regulation of TGFβ expression was observed at both 6 and 24 hours in stimulated blood 
samples from African elephants. Down-regulation of TGFβ was also previously observed in 
unstimulated whole blood samples of TB-seropositive Asian elephants (Landolfi et al., 2010). 
In addition, the production of TGFβ has been shown to have inhibitory effects on B 
lymphocytes (Kehrl et al., 1986; Sanjabi, Oh and Li, 2017). However, previous studies in Asian 
elephants with TB have shown a robust humoral response in infected individuals (Greenwald 
et al., 2009). Possibly, such findings could be due to down-regulation of TGFβ expression 
during immune responses in elephants. More research is needed to determine the role that this 
cytokine plays in elephants. Although the low expression of this gene limits its use as a single 
diagnostic marker in African elephants, the observed slight down-regulation could be useful in 
a biomarker panel, as seen in humans (Dhanasekaran et al., 2013; Han et al., 2018). 
When cytokine expression was compared among individual elephants, there appeared to be 
high and low expressors, especially of IL10 and TNF, at 24 hours. However, there was poor 
correlation between fold change values of these cytokines by the same individual animal. 
Similarly, this was also true for the correlation between TNF and TGFβ, which may be expected 
since TNF is a pro-inflammatory cytokine and IL10 and TGFβ are anti-inflammatory (Wang, 




correlation was observed in values for the two anti-inflammatory cytokines IL10 and TGFβ, 
however the role of these cytokines in elephant immune responses requires further 
investigation. 
Limitations in this study were the small number of samples used for cytokine gene 
sequencing (n=2) and temporal patterns (n=3) of cytokine expression in response to mitogen 
stimulation. In addition, all elephants were free-ranging individuals, requiring capture and 
chemical immobilization, which may have resulted in acute physiological stress responses 
impacting immune stimulation. Therefore, further studies with a larger cohort of African 
elephants are needed to confirm the observations reported. In addition, a comparison of 
mitogen responses using trained African elephants to evaluate the influence of capture on 
cytokine expression would facilitate interpretation. Importantly, additional cytokine genes 
should be investigated to provide a broader set of tools for studying immune responses in this 
species. 
2.5. Conclusion 
To our knowledge, this is the first study investigating cytokine biomarkers in African 
elephants using real-time RT-qPCR. The cytokine sequences used in this study are the first 
confirmed mRNA transcripts for this species. The up-regulation of IL10 and TNF, as well as 
the slight down-regulation of TGFβ demonstrate the possible use of these biomarkers to 
measure immune responses to inflammatory and infectious diseases. The knowledge generated 





Chapter 3: Evaluation of mycobacterial antigen stimulated responses in African 
elephant (Loxodonta africana) whole blood using cytokine gene expression assays 
In this chapter, African elephant (n = 11) whole blood samples were stimulated with antigens 
ESAT6/CFP10, M. avium purified protein derivative (PPDa) and M. bovis purified protein 
derivative (PPDb) for 6 hours. Following antigen stimulation, RT-qPCRs for target genes IL10, 
TGFβ, and TNF were performed and normalized to reference gene GAPDH, to determine 




Tuberculosis (TB) in elephants is most commonly caused by infection with the intracellular 
pathogen Mycobacterium tuberculosis (M. tb), a member of the Mycobacterium tuberculosis 
complex (MTBC) (Fowler, 2008), while a small number of cases caused by Mycobacterium 
bovis (M. bovis) have been reported (Lyashchenko et al., 2006; Goosen et al., 2020a). 
Tuberculosis is a chronic infection, with antemortem signs often absent until the disease has 
progressed to advanced stages (Mikota and Maslow, 2011; Paudel and Toshio, 2016). Since 
elephants with M. tb infection were documented in the USA in the 1990’s, many other cases 
have been reported globally (Mikota et al., 2001; Paudel and Sreevatsan, 2020). While most of 
these were identified in captive Asian elephants (Elephas maximus), there have been several 
cases of TB documented in free-ranging Asian elephants in Sri Lanka and India (Perera et al., 
2014; Chandranaik et al., 2017; Zachariah et al., 2017). To date, much of the disease research 
has focused on infection in Asian elephants, however, African elephants (Loxodonta africana) 
are also susceptible and impacted by this disease. The first fatal cases of TB in free-ranging 
African elephants were documented in Tsavo East National Park, Kenya (Obanda et al., 2013) 
and the Kruger National Park (KNP) in South Africa (Miller et al., 2019). Two cases of M. tb 
infection were also diagnosed in African elephants at the South African National Biodiversity 
Institute National Zoological Gardens (SANBI-NZG) (unpublished data). Since TB in 
elephants is considered an anthropozoonotic disease, elephant interactions with humans have 
raised concerns with regards to impacts on conservation (Zachariah et al., 2017; Lainé, 2018). 
African elephants are listed as vulnerable on the International Union for Conservation of 
Nature’s (IUCN) Red List of Threatened Species, due to the ongoing threat of poaching and 




fragmentation and animal-human conflict (Fowler, 2008; Sach et al., 2019; de Sales, Anastácio 
and Pereira, 2020), however the threat of disease should not be underestimated. It is thus 
important to understand the effects of TB in this species. 
There are currently only a limited number of diagnostic tests that have been validated for 
the detection of TB in elephants. Current antemortem tests include serological assays and 
mycobacterial culture (Fowler, 2008; Greenwald et al., 2009; Lyashchenko et al., 2012). 
Serological assays can provide important information regarding previous exposure to MTBC 
organisms, however, seropositivity does not equate with current infection. There is also a 
paucity of data regarding the seroprevalence of MTBC in free-ranging African elephants, with 
the first study reported recently by Kerr et al. (2019). This study was performed retrospectively 
on serum samples from the KNP population, and found an estimated prevalence of 6%, based 
on results from the Dual Path Platform (DPP®) Vet TB Assay for Elephants (DPP, Chembio 
Diagnostic Systems, Inc., Medford, NY, USA), and 9% based on the Elephant TB STAT-PAK 
Assay (Chembio). Several studies have used interferon-γ release assays (IGRAs) in Asian 
elephants, however their use in African elephant populations has not been investigated 
(Angkawanish et al., 2013; Paudel et al., 2016; Songthammanuphap et al., 2020). 
Mycobacterial culture of respiratory samples, including trunk wash (TW) and bronchoalveolar 
lavage (BAL) samples, is currently viewed as the gold standard for confirming MTBC 
infection, however respiratory sample collection and mycobacterial culture are expensive, 
laborious and samples, in particular TW, are often contaminated, negating results (Hermes et 
al., 2018). Therefore, rapid, and accurate antemortem diagnostic tests are needed.  
Since antigen-specific cell-mediated immune (CMI) responses are detectable following M. 
tb infection (Abegglen et al., 2018), cytokine gene expression assays (GEAs) have been used 
to diagnose MTBC infection in elephants and various other species (Landolfi et al., 2010; 
Clarke et al., 2017; Higgitt et al., 2017; Olivier et al., 2017). A study done by Landolfi et al. 
(2010) reported significantly higher levels of tumor necrosis factor (TNF) and lower levels of 
transforming growth factor beta (TGFβ) gene expression in unstimulated peripheral whole 
blood samples from TB seropositive Asian elephants using real-time, reverse-transcription 
quantitative PCR (RT-qPCR). Since GEAs make use of species-specific primers, which are 
designed to target a cytokine gene of interest, in combination with commercially available 
qPCR master mixes, application may be more feasible and cost-effective than antibody-based 
tests in species where antibodies are not commercially available (Landolfi et al., 2014; 




levels of gene expression following 6-hour incubation with negative control (nil), MTBC 
antigens (PPDa, PPDb, QFT-TB2) and mitogen (PWM) stimulation of heparinized whole 
blood collected from African elephants. Stimulants were selected to provide an indication of 
circulating/baseline cytokine levels (nil); response to environmental mycobacteria (PPDa); 
response to M. bovis antigens (PPDb); response to TB-specific antigens (QFT-TB2), and 
general immune activation (PWM). Additionally, the differential PPD response (PPDb-PPDa) 
was also calculated as an indication of a TB-specific response. Previously designed and 
optimized RT-qPCRs for target genes interleukin 10 (IL10), TGFβ, and TNF, normalized to 
reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (de Waal et al., 2021; 
Chapter 2), were used to assess their potential utility as biomarkers for TB in elephants. During 
the development of the RT-qPCRs (de Waal et al., 2021; Chapter 2), 24-hour whole blood 
stimulation was determined as optimal in African elephants. However, as heparinized whole 
blood was collected prior to development of RT-qPCRs, only samples stimulated with the panel 





3.2. Materials and Methods 
3.2.1. Animals and sample collection 
Samples for this study were opportunistically collected from 11 free-ranging African bull 
elephants from Kruger National Park (KNP) in South Africa, which is endemic for M. bovis, 
during routine immobilizations for management or veterinary procedures. Whole blood was 
collected into BD Vacutainer® lithium heparin tubes (Becton Dickinson, Franklin Lakes, NJ, 
USA) and kept at room temperature until transported to the lab within 4-6 hours of collection. 
In addition, serum (BD Vacutainer®) and respiratory samples (BAL and TW) were also 
collected. At the time of sampling, four African elephants were classified as young adults ( 
24 years), while seven were classified as adults ( 25 years). 
Ethical approval for the sample acquisition and testing of these animals was granted by the 
Stellenbosch University Animal Care and Use Committee (SU-ACU 2018-6308), and South 
African National Parks Animal Care and Use Committee (SANParks Research Agreement 
BUSP1511). Section 20 approval was granted by the South African Department of Agriculture, 
Land Reform and Rural Development (DALRRD) formerly the Department of Agriculture, 
Forestry, and Fisheries (DAFF Section 20: 12/11/1/7/6). 
3.2.2. Classification of disease status 
The MTBC infection status of each African elephant was evaluated as follows. Serum 
samples were classified as serologically negative or positive using the DPP® Vet TB Assay for 
Elephants (Chembio) as previously described (Kerr et al., 2019). This assay uses MTBC 
antigens, MPB83, early secretory antigenic target 6 kDa (ESAT6), and culture filtrate protein 
10 kDa (CFP10), to detect the presence of antigen-specific antibodies in sera, which provides 
an indirect diagnosis of TB in elephants (Greenwald et al., 2009). 
Respiratory samples (TW and BAL) were collected for mycobacterial culture using the BD 
BACTEC™ MGIT™ 960 automated Mycobacterial Detection System (Becton Dickinson 
Biosciences). Trunk wash was performed by infusing sterile saline through a polypropylene 
tube placed into the trunk of the immobilized elephant, the trunk was then raised and lowered 
repeatedly, after which fluid was aspirated into a sterile container. After transport to the lab, 
samples were concentrated by centrifugation, and stored in 4 mL aliquots at -80°C prior to 
analysis (Goosen et al., 2020a). Bronchoalveolar lavage samples were collected using a flexible 




trunk wash samples prior to analysis. Concentrated BAL or TW samples (4 mL) were then 
decontaminated and processed for mycobacterial culture as previously described by Goosen et 
al. (2014). Each elephant was then classified as either MTBC infected or uninfected based on 
the presence or absence of mycobacterial growth and serological results. 
3.2.3. Whole blood stimulation 
For each African elephant, heparinized whole blood was stimulated using tubes prepared as 
follows: 25 μl phosphate buffered saline (PBS; nil), PPDa (Onderstepoort Biological Products, 
Pretoria, South Africa) (final concentration 2750 IU/ml), PPDb (Onderstepoort Biological 
Products) (final concentration 3300 IU/ml) and pokeweed mitogen (PWM; Sigma-Aldrich, St. 
Louis, MO, USA) (final concentration 10 μg/ml), were added to separate 2 mL microtubes 
(Eppendorf, Hamburg, Germany), respectively. For each set, 250 μl of heparinized whole blood 
was added to each tube. An additional 1 mL of whole blood was stimulated using the 
QuantiFERON®-TB Gold Plus TB2 tube (QFT; Qiagen, Venlo, The Netherlands), containing 
ESAT6/CFP10 antigens. Tubes were inverted several times and incubated at 37°C for 6 hours. 
Following incubation, whole blood in the QFT tube was transferred to a 2 mL microcentrifuge 
tube after which all tubes were centrifuged at 2 000 x g for 15 minutes. The plasma fraction 
was harvested, and the remaining cell pellet resuspended in 1 mL RNALater® Solution 
(Ambion, Foster City, CA, USA). The separated plasma, and cell pellets stabilized in 
RNALater®, were stored at -80°C until analyzed. 
3.2.4. RNA extraction and reverse transcription 
The RiboPure™-Blood Kit (Ambion) was used to extract RNA from RNALater® stabilized 
cell pellets, as previously described (de Waal et al., 2021; Chapter 2). The first elution was 
performed using 30 µl elution buffer, incubated for 5 minutes at room temperature, and 
centrifuged for 30 seconds at 16 000 x g. The second elution was performed using 30 µl elution 
buffer, incubated for 3 minutes, and centrifuged for 1 minute at 16 000 x g to obtain a final 
volume of 60 µl total RNA. The quantity (ng) and A260/280 and A260/230 ratios of the 
extracted RNA were measured using the Nanodrop 1000 spectrophotometer (ThermoFisher 
Scientific, Wilmington, DE, USA), after which RNA was stored at -80°C prior to reverse 
transcription. 
An estimated 200 ng of RNA was reverse transcribed to 20 μl of cDNA, using the 
QuantiTect® Reverse Transcription Kit (Qiagen, Hilden, Germany). To achieve this, genomic 




from the extracted RNA, after which reverse transcription was performed according to 
manufacturer’s instructions and cDNA stored at -20°C. 
3.2.5. RT-qPCR 
Reverse-transcriptase quantitative PCR (RT-qPCR) assays, previously developed and 
validated for African elephant whole blood RNA samples (de Waal et al., 2021; Chapter 2), 
were used to measure cytokine gene expression of TNF, IL10, and TGFβ, relative to the 
reference gene GAPDH, following antigen stimulation. Primers for each of the target and 
reference genes are listed in Table 3.1. Each gene target was amplified separately in a 10 µl 
PCR reaction containing 1 µl of cDNA, 5 µl iTAQ™ Universal SYBR® Green Supermix (Bio-
Rad Laboratories, Hercules, CA, USA), 0.4 μl of each forward and reverse primer (final 
concentration of 400 nM), and nuclease-free water. The qPCR cycling conditions were as 
follows: polymerase activation at 95°C for 30 seconds, followed by 40 cycles of denaturation 
at 95°C for 5 seconds, and annealing and elongation at 60°C for 30 seconds. Melt-curve 
analysis was performed over a 65–95°C range with increased increments of 0.5°C every 5 
seconds. Standard melt curve analysis was used to confirm the specificity of RT-qPCRs. All 
samples were run on the CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad). 
 
Table 3.1: RT-qPCR primer sequences for reference (GAPDH) and target cytokine genes 
(IL10, TGFβ, and TNF) used to measure gene expression in African elephant whole blood 
following antigen stimulation. 
Gene Forward Primer (5' → 3') Reverse Primer (5' → 3') DM peak 
(°C) 
GAPDH ACGTGTCAGTGGTGGATCTG GCCTGCTTCACCACCTTCTT 78.5 
IL10 CGGTGGAGCAAGTGAAGGAA TGTCAAACTCACTCATGGCC 77.5 
TGFβ TCCACCGAGAAGAACTGCTG GCTCCAGATGTAAGGGCAGG 85 
TNF CCTGTAGCACACGTTGTAGC CATCGGAAGGCACCATCAGC 82 




3.2.6. Data analysis 
The relative fold change (2−ΔΔCq) was used to measure abundance of the target transcript and 
up- or down-regulation of the target genes in response to antigen stimulation, which was 
calculated as previously described (Livak and Schmittgen, 2001). Up-regulation was classified 
as a minimum fold change (2−ΔΔCq) of > 1, while fold change < 1 was classified as down-
regulation (Radonic et al., 2004; Schmittgen and Livak, 2008). To obtain the differential PPD 
response, fold change following PPDa stimulation was subtracted from fold change following 
PPDb expression (2−ΔΔCq PPDb - 2−ΔΔCq PPDa). Thereafter, overall differences in gene 
expression in response to PPDa, PPDb, differential PPD response (PPDb-PPDa) and QFT-TB2 
stimulation, were compared using the Friedman test. A Dunn’s multiple comparison test was 
used to determine statistically significant differences following antigen stimulations, and a p-
value < 0.05 was considered statistically significant. Statistical analyses were performed using 







Following RNA extraction, total RNA yield from the African elephant whole blood samples 
ranged from 174 to 2214 ng (median: 492 ng). The A260/280 ratio ranged from 1.7 to 2.2 
(median: 2.0) and the A260/230 ratio ranged from 0.1 to 2.8 (median: 1.6). While A260/230 
ratios fell outside the recommended range, all samples were included based on the limited 
availability of samples with all antigen stimulations. 
Samples were opportunistically obtained from 11 African elephants from a M. bovis-
endemic area for use in this study. Of the 11 African elephants, 10 were classified as MTBC 
uninfected based on serological and mycobacterial culture results, while 1 elephant was 
classified as MTBC seropositive, but mycobacterial culture negative. For each of the target 
genes (TNF, IL10, and TGFβ), the fold change observed for the seropositive (suspect immune 
sensitized) African elephant did not differ significantly from the ten uninfected African 
elephants, and this animal was therefore included in all data analyses going forward. 
With the exception of responses to QFT-TB2 (ESAT6/CFP10) which were slightly down-
regulated, elevated levels of IL10 gene expression (median fold change) were observed 
following antigen (PPDa, PPDb) and PWM stimulation (Figure 3.1; Table 3.2). Slight down-
regulation of IL10 expression was also observed with the calculation of the differential PPD 
response. Significantly higher IL10 gene expression was observed when PPDa and PPDb were 
compared to QFT-TB2 (p = 0.0046 and p = 0.0002, respectively); and PPDb was compared to 
the calculated differential PPD response (p = 0.0121). Two elephants had visibly higher IL10 





Figure 3.1: Gene expression of IL10 measured in whole blood from 11 African elephants, 
following M. avium purified protein derivative (PPDa); M. bovis purified protein derivative 
(PPDb); early secretory antigenic target 6 kDa/culture filtrate protein 10 kDa (ESAT6/CFP- 
10; QFT-TB2) and pokeweed mitogen (PWM) stimulation, and calculation of the differential 
PPD response (PPDb-PPDa). Gene expression was measured following 6 hours of incubation. 
For each group, seronegative and mycobacterial culture negative elephants (n = 10) are 
indicated in blue; while one seropositive, mycobacterial culture negative elephant is indicated 
in purple. The median fold change of each group is indicated by a solid horizontal line. The 
dotted line on the y-axis indicates the minimum fold change (2−ΔΔCq >1) for expression to be 





Table 3.2: Gene expression for IL10, TGFβ, and TNF, calculated as median fold change (95% 
CI), following 6-hour stimulations of African elephant whole blood with M. avium purified 
protein derivative (PPDa); M. bovis purified protein derivative (PPDb); calculation of the 
differential PPD response (PPDb-PPDa); early secretory antigenic target 6 kDa/culture filtrate 
protein 10 kDa (ESAT6/CFP10; QFT-TB2) and pokeweed mitogen (PWM). 
Gene Median Fold Change (2−ΔΔCq)  
PPDa PPDb Differential 
PPD (PPDb – 
PPDa) 
QFT-TB2 PWM 
IL10 2.49  
(-1.25 - 14.10) 
3.34  
(1.33 - 11.90) 
0.56 
(-3.65 – 4.07) 
0.18 
(0.06 – 0.71) 
1.60 
(-1.01 – 11.80) 
TGFβ 0.56 
(0.041 – 1.15) 
0.65 
(0.31 – 1.65) 
-0.02 
(-0.24 – 0.64) 
0.55 
(0.38 – 0.86) 
0.20 
(0.11 – 0.45) 
TNF 0.65 
(-0.60 – 4.09) 
0.62 
(-0.10 – 4.25) 
0.04 
(-0.72 – 1.37) 
0.34 
(0.11 – 1.09) 
0.40 
(0.19 – 1.89) 
 
Slight down-regulation of TGFβ expression was observed following all stimulations (Figure 
3.2; Table 3.2). Despite low levels of gene expression, a significantly higher gene expression 
(median fold change) was observed when PPDa was compared to the calculated differential 
PPD response (p = 0.005); as well as when PPDb was compared to the calculated differential 
PPD response (p = 0.012) (Figure 3.2). One of the elephants which had high IL10 responses to 
antigens, also had visibly higher TGFβ expression compared to the rest of the group following 





Figure 3.2: Gene expression for TGFβ measured in whole blood from 11 African elephants, 
following M. avium purified protein derivative (PPDa); M. bovis purified protein derivative 
(PPDb); early secretory antigenic target 6 kDa/culture filtrate protein 10 kDa (ESAT6/CFP- 
10; QFT-TB2) and pokeweed mitogen (PWM) stimulation, and calculation of the differential 
PPD response (PPDb-PPDa). Gene expression was measured following 6 hours of incubation. 
For each group, seronegative and mycobacterial culture negative elephants (n = 10) are 
indicated in blue; while one seropositive, mycobacterial culture negative elephant is indicated 
in purple. The median fold change of each group is indicated by a solid horizontal line. The 
dotted line on the y-axis indicates the minimum fold change (2−ΔΔCq >1) for expression to be 
considered up-regulated. * p ≤ 0.05 and ** p ≤ 0.01. 
 
Like TGFβ, very slight down-regulation of TNF gene expression was observed following 
all stimulations (Figure 3.3; Table 3.2). The elephant with visibly higher IL10 and TGFβ 
expression, also had visibly higher TNF expression compared to the rest of the group following 
PPDa, PPDb, and PWM stimulations. A second animal had visibly higher expression following 
PPDb and PWM stimulation, as well as the calculated PPD differential response. Again, despite 




observed when PPDb was compared to the calculated differential PPD response (p = 0.005); 
as well as when PPDb was compared to QFT-TB2 (p = 0.03) (Figure 3.3).  
 
Figure 3.3: Gene expression of TNF measured in whole blood from 11 African elephants, 
following M. avium purified protein derivative (PPDa); M. bovis purified protein derivative 
(PPDb); early secretory antigenic target 6 kDa/culture filtrate protein 10 kDa (ESAT6/CFP- 
10; QFT-TB2) and pokeweed mitogen (PWM) stimulation, and calculation of the differential 
PPD response (PPDb-PPDa). Gene expression was measured following 6 hours of incubation. 
For each group, seronegative and mycobacterial culture negative elephants (n = 10) are 
indicated in blue; while one seropositive, mycobacterial culture negative elephant is indicated 
in purple. The median fold change of each group is indicated by a solid horizontal line. The 
dotted line on the y-axis indicates the minimum fold change (2−ΔΔCq >1) for expression to be 






Following the first fatal case of TB due to infection with M. tb in 2018 (Miller et al., 2019) 
two additional elephants in KNP have been found to have incidental M. bovis infections 
(Goosen et al., 2020a; Miller unpublished data). The occurrence of infection due to both M. tb 
and M. bovis raises concern as African elephants are ecologically and economically important 
for conservation (Blignaut, de Wit and Barnes, 2008; Kerley et al., 2008). The TB cases have 
resulted in movement restrictions being placed on this population by DALRRD, to prevent 
possibly infected elephants from introducing MTBC into naïve populations through 
translocation (Miller et al., 2019). In this chapter, levels of gene expression were measured 
following 6-hour TB antigen stimulation of heparinized whole blood collected from African 
elephants in KNP, to determine the use of a previously designed cytokine GEA (de Waal et al., 
2021; Chapter 2) for detection of MTBC sensitization. 
Eleven African elephants from KNP were sampled for this study. Ten elephants were MTBC 
uninfected, based on serologic and mycobacterial culture results, while one elephant was 
classified as suspect immune sensitized due to a positive serological response, and a negative 
mycobacterial culture result. While mycobacterial culture is seen as the gold standard for TB 
diagnosis in elephants, it has also been shown to have varying sensitivity, with a positive 
serodiagnosis often being made years before mycobacterial culture confirmation (Lyashchenko 
et al., 2006; Greenwald et al., 2009). Thus, even though a negative mycobacterial culture result 
ruled out active shedding, the detection of antibodies to MTBC antigens was considered 
indicative of previous exposure. 
Gene expression in the single suspect immune sensitized African elephant was comparable 
to gene expression (median fold change) observed for the MTBC uninfected animals. The lack 
of significantly different levels of gene expression in this elephant could be due to a difference 
in the dominant immune responses observed in various species, with elephants having a strong 
early humoral response, or may reflect an early infection that has not yet stimulated a cell-
mediated immune response, or possibly a false positive serological result (Greenwald et al., 
2009; Miller et al., 2018). It is also important to note that median fold change for all cytokines 
were below 2, except for IL10 expression following PPDa and PPDb stimulation. This may 
indicate a lack of significant response to antigen stimulation for all samples, likely due to 
suboptimal incubation time, as 24 hours was previously identified as the optimal incubation 




sensitization in these elephants. However, due to samples being collected prior to GEA 
optimization, only samples stimulated with antigens for 6 hours were available, which is one 
of the limitations of this study. 
Low levels of up-regulation were observed for IL10, while median TGFβ and TNF 
expression showed very slight down-regulation, in whole blood samples following PWM 
stimulation. These immune responses, albeit low, may indicate the viability of the whole blood 
samples. Interestingly, these levels of expression were comparable with the lowest levels of 
expression in previous 6-hour cohorts (de Waal et al., 2021; Chapter 2). These overall 
expression levels were also visibly similar to the unstimulated, systemic immune responses 
observed in seronegative and seropositive elephants by Landolfi et al. (2010). These 
comparable expression levels between samples in this study and baseline immune responses in 
Asian elephants, may indicate suboptimal PWM stimulation, and therefore inadequate immune 
activation. This may be due to the suboptimal incubation time or poor response to PWM as the 
selected mitogen.  
The anti-inflammatory cytokine IL10 had the highest levels of gene expression, with up-
regulation in elephant whole blood measured following PPDa and PPDb stimulation. These 
reactions are likely due to cross-reactivity to environmental non-tuberculous mycobacteria, 
since PPDs are a crude mixture of proteins with conserved homologous regions to various 
mycobacterial species (Borsuk et al., 2009; Cho et al., 2012). Expression following stimulation 
with the TB specific antigen ESAT6/CFP10 (QFT-TB2), as well as the calculated differential 
PPD response (specific TB response) showed slight down-regulation of IL10. The cytokine 
IL10 has been shown to limit immune function during TB, and contribute to pathogenesis, 
therefore, down-regulation or lack of expression may be beneficial to help fight infection. 
However, a low or negligible response is also expected in an uninfected cohort (Redford, 
Murray and O’Garra, 2011). 
Down-regulation of median TGFβ and TNF expression levels in whole blood following all 
antigen stimulations was observed, albeit at low levels. For TGFβ, the lowest level of 
expression was seen following calculation of the differential PPD response, although this may 
be an artifact of the calculation since the median fold changes for both PPDs were less than 
one. This may be expected in samples from uninfected African elephants. In Asian elephants, 
although not statistically significant, lower levels of TGFβ were measured in unstimulated 




(Landolfi et al., 2010). When Asian elephant PBMCs were stimulated with mycobacterial 
antigens, no significant difference in TGFβ expression was observed between TB-seropositive 
and seronegative animals (Landolfi et al., 2014), which is similar to what was observed in our 
study. However, as samples from only one seropositive animal was available, definitive 
conclusions cannot be drawn.   
A study done by Landolfi et al. (2010) showed higher expression levels of TNF in 
unstimulated peripheral whole blood samples of TB-seropositive elephants compared to 
seronegative elephants. Similarly, Landolfi et al. (2014) showed higher levels of TNFα mRNA 
extracted from PMBCs of seropositive Asian elephants versus seronegative elephants 
following 2-day stimulation with PPDb and CFP10, indicating its utility as a biomarker for TB. 
The overall down-regulation of TNF observed in our study might be due to the shorter 6-hour 
incubation, as the optimal time point for whole blood stimulation was previously determined 
to be 24 hours (de Waal et al., 2021; Chapter 2). This suggests that a longer incubation period 
should be used with African elephant samples. Therefore, additional studies should be used to 
determine optimal time points for antigen stimulation. 
A significant amount of individual variation among elephants was observed for cytokine 
gene expression following mitogen and antigen stimulations. Such variation presents another 
obstacle for interpretation of expression level differences between groups of seropositive and 
negative animals. Samples from three seronegative elephants had greater cytokine gene 
expression levels compared to the group. Elephant 6 had higher levels of expression for IL10 
and TNF following PPDa, PPDb and PWM stimulations, as well as higher levels of expression 
of TGFβ following PPDa and PPDb stimulations. As higher levels of expression were seen 
following PPDa stimulation as well as PWM, this heightened response is likely antigen non-
specific. Similarly, in samples from elephant 8, higher levels of expression for IL10 were 
observed following PPDa, PPDb, and PWM stimulations, also indicating non-specific 
expression. Elephant 7 had higher levels of TNF expression following PPDb and PWM 
stimulations, as well as the calculation of differential PPD response. However, there was no 
evidence that the responses in these elephants were due to TB specific immune sensitization. 
Immune responses elicited by antigens PPDa and PPDb have been used to diagnose TB in 
species such as African buffalo and common warthogs (Roos et al., 2016; Bernitz et al., 2018a). 
A study by Landolfi et al. (2014) was able to differentiate between seronegative and TB 




PPDb and PPDa stimulated PBMC cultures. In the current study, PPDs were used to elicit a 
TB specific cytokine expression response for diagnosis in African elephants. However, as there 
was only one suspect immune sensitized animal, any differences between infected and 
uninfected African elephants could not be detected. In samples from the uninfected cohort, 
changes in cytokine gene expression following both PPDa and PPDb stimulations were 
observed, indicating responses to shared antigens, as PPDs contain a crude mixture of proteins 
(Cho et al., 2012). When the target gene abundance was calculated as a differential PPD 
response (PPDb-PPDa), median gene expression levels of all three cytokines was comparable 
to those following QFT-TB2 stimulation. However, as mentioned previously, these antigen 
responses were also measured following suboptimal incubation times in elephants without 
evidence of specific TB immune sensitization, and future studies should investigate the 
measurement of gene expression following 24-hour stimulation of whole blood with these 
antigens in known immune sensitized animals.  
3.5. Conclusion 
The aim of this study was to measure levels of cytokine gene expression in African elephant 
blood following different mycobacterial antigen stimulation, to determine the potential utility 
of IL10, TGFβ, and TNF as biomarkers for MTBC infection. The up-regulation of IL10, and 
slight down-regulation of both TNF and TGFβ in mitogen-stimulated African elephant whole 
blood suggest that they should be investigated further for inclusion in a biomarker panel. 
However, additional experiments are required to confirm these findings. Samples were only 
available from ten elephants that did not have any evidence of MTBC exposure which limited 
the interpretation of results, and no definitive conclusions can be drawn regarding the use of 
these cytokine genes as potential biomarkers for TB. As the optimal time point for stimulation 
was previously determined as 24 hours (de Waal et al., 2021; Chapter 2), future studies will 
need to determine the levels of gene expression with longer incubation times for stimulation, 
and with confirmed MTBC infected African elephants to determine the use of these candidate 





Chapter 4: General Discussion 
This chapter provides a summary of our results and highlights the principle interpretations, 
with a focus on how these relate to the literature. In addition, limitations of the study are 
discussed.
 
African elephants are a charismatic species, however, there are large knowledge gaps 
regarding understanding of their immune system. The capability to evaluate immune responses 
is crucial for developing diagnostic tools as well as providing insight into comparative biology. 
Therefore, this project focused on investigating cell-mediated immune responses, specifically 
using cytokine gene expression, to identify biomarkers of immune activation and provide a 
foundation for techniques that can be applied to diagnostic test development. 
The findings in this project have demonstrated that African elephant cytokine genes can be 
amplified using primers based on sequences from Asian elephants as well as other species, and 
resulted in the first report of full coding sequences for a number of cytokine (CXCL9, CXCL10, 
IFNγ, IL4, IL12, TGFβ) and reference (ACTB, GAPDH, YWHAZ) genes, as well as partial 
sequences (B2M, IL10, TNF) for this species. Using these sequences, African elephant specific 
primers were designed and used in RT-qPCR assays that could measure changes in gene 
abundance of cytokines IL10, TNF, TGFβ, normalized to a reference gene GAPDH, in whole 
blood stimulated with mitogen (PWM). The development of these GEAs then enabled a pilot 
study to determine if changes in cytokine gene expression in blood stimulated with 
mycobacterial antigens from elephants in a M. bovis endemic park, would provide evidence 
that these cytokines could be used as biomarkers for TB. 
Mycobacterial infections, caused by M. tb and M. bovis, have been diagnosed in both captive 
and free-ranging Asian and African elephants (Mikota et al., 2001; Lewerin et al., 2005; 
Mikota, 2008; Angkawanish et al., 2010; Verma-Kumar et al., 2012; Obanda et al., 2013; 
Perera et al., 2014; Chandranaik et al., 2017; Zachariah et al., 2017; Miller et al., 2019), 
showing that both are susceptible to this disease. However, very few reliable diagnostic tests 
are available for these species and may have suboptimal performance or other logistical 
challenges in obtaining results (Mikota et al., 2001; Fowler, 2008; Paudel and Toshio, 2016; 
Hermes et al., 2018). In addition, other than mycobacterial culture and PCR, the current tests 
(serology, IGRA) are based on detection of host immune responses and there has been limited 




Paudel et al., 2016; Songthammanuphap et al., 2020). Although limited studies on immune 
responses in Asian elephants have been reported (Landolfi et al., 2009, 2010, 2014; 
Angkawanish et al., 2013; Paudel and Toshio, 2016), there are fewer investigations of immune 
responses in African elephants (Greenwald et al., 2009; Lyashchenko et al., 2012; Edwards et 
al., 2020). Thus, knowledge about the role of the immune system in health and disease, as well 
as diagnostic tools to assess these, are needed to improve our understanding, welfare, and 
facilitate conservation programs for these species. Consequently, this thesis described the 
development of novel cytokine GEAs to measure CMI responses in African elephants.  
Cytokine GEAs and cytokine release assays measure immune mediators of CMI responses, 
which can be used to detect antigen-specific immune sensitization or general immune 
activation (using mitogens) in vitro after incubation of blood. These indirect immunological 
assays provide insights into the host’s responses to different pathogens and are the basis of 
many blood-based diagnostic tests (Maas, Michel and Rutten, 2013; Clarke et al., 2017; 
Chileshe et al., 2019). Since cytokine protein detection often requires species-specific 
antibodies, limiting their use in novel species, cytokine GEAs are an alternative technique to 
measure CMI responses. This approach was selected to investigate in vitro CMI responses in 
African elephants in this project.  
Cytokine GEAs have been used to detect mycobacterial infection in Asian elephants and 
various species (Higgitt et al., 2017; Olivier et al., 2017; Roos et al., 2019), and have been 
shown to have high sensitivity in certain species (Maas, Michel and Rutten, 2013; Miller et al., 
2019). During the development of cytokine RT-qPCRs for African elephants, primer sequences 
were based on predicted African elephant mRNA transcripts as well as other species including 
Asian elephant and warthog, which allowed amplification and sequencing of the African 
elephant cytokine transcripts. This approach has been used when developing GEAs in novel 
species and is based on the conservation of cytokine sequences, especially in related organisms. 
For example, mRNA sequences of the domestic cat and dog were used to design primers for 
lion cytokine amplification (Olivier et al., 2017), and domestic cat and dog, domestic ferret 
(Mustela putorius furo) and the giant panda (Ailuropoda melanoleuca) were used to amplify 
cytokine genes in the spotted hyena (Higgitt et al., 2017). Therefore, the ability to design 
primers for PCR amplification of genes from a new species (African elephant) provides an 




Despite successful sequencing of nine cytokine and reference genes from African elephant 
blood cells, varying amplification led to only partial coding sequences for three genes B2M, 
IL10, and TNF. Possible SNPs located in the annealing regions may be the cause of varying 
amplification, as well as the possible formation of secondary structures which alter annealing 
(Derveaux, Vandesompele and Hellemans, 2010). These factors would also explain the 
inconsistent amplification of CXCL9, CXCL10, and IFNγ, using qPCR primers, as well as the 
out-of-range efficiency of IL12. It is also possible that species differences could influence the 
efficient amplification of CXCL9, CXCL10, and IFNγ since Asian elephant primers were used 
to initially amplify IFNγ for sequencing and warthog sequences used for CXCL9 and CXCL10. 
While some temperature optimization was performed during this study, additional studies to 
optimize other PCR conditions and re-design of primers for these cytokines should be 
performed to improve results for GEAs that were unsuccessful.  
In order to determine if the cytokine GEAs could detect immune activation in mitogen 
stimulated African elephant blood, real-time RT-qPCRs were developed and optimized. The 
reference gene GAPDH was identified as the most stable and efficiently expressed gene, and 
was compatible with IL10, TGFβ, and TNF for use as in the African elephant cytokine GEAs. 
The reference and target genes identified in African elephant blood were similar to those 
identified during the development of real-time RT-qPCRs for Asian elephants (Landolfi et al., 
2009).  Because only three target genes met the initial criteria for qPCR development, these 
were used to investigate immune activation in African elephants.  
The findings in a pilot study, to determine the optimal incubation time for cytokine gene 
expression following mitogen stimulation, revealed that expression levels for IL10, TGFβ, and 
TNF showed an unexpected high response measured in all three genes at 0 and 6 hours, 
followed by increased expression at 24 hours. Since blood samples were collected from free-
ranging elephants for this study, the “fight-or-flight” response may have resulted in the early 
peak expression observed at the early time points. The release of catecholamines has been 
shown to induce both pro-inflammatory and anti-inflammatory gene expression in 
macrophages following physiological stress (Barnes, Carson and Nair, 2015; Shaw et al., 
2018). Alternatively, immune activation may have occurred during the handling of the samples 
and initial processing of the whole blood. However, since only three animals were used for the 
temporal expression component of this study, interpretations of results are limited. In the Asian 
elephant studies, blood was collected from trained animals, and RNA extracted from 




2009). This early response must be considered in future studies, and temporal cytokine gene 
expression responses should be measured in African elephants trained for blood collection to 
determine the significance of these findings. 
Following identification of gene expression peaks after 6 and 24 hours of incubation, a 
cohort of 16 African elephants was used to investigate immune activation. Up-regulation of 
TNF expression was observed at both 6 and 24 hours, with gene expression at 24 hours being 
significantly higher. This high level of expression could indicate the importance of TNF to 
enhance immune responses in African elephants, as TNF is considered a master regulator of 
pro-inflammatory cytokine production, leading to the induction of IL10, TGFβ, and IFNγ 
(Wang, Czura and Tracey, 2003; Parameswaran and Patial, 2010). This cytokine has also been 
shown to be involved in granuloma formation during M. tb infection, and thus has an important 
role in activation of immune cells at the site of infection (Walzl et al., 2011; Etna et al., 2014). 
It also functions to inhibit differentiation of macrophages, induce apoptosis in mature T-cells, 
and enhance natural killer cell function (Rath and Aggarwal, 1999; Wang, Czura and Tracey, 
2003), thus helping clear infection. The increased level of TNF expression in our study supports 
the potential use of this cytokine as a biomarker for immune activation in African elephants. 
The two anti-inflammatory cytokines IL10 and TGFβ showed variable expression in 
mitogen stimulated African elephant blood. Up-regulation of IL10 expression was observed at 
both 6 and 24 hours after mitogen stimulation. This cytokine has been shown to inhibit the 
production of inflammatory cytokines and enhance activation, differentiation, and proliferation 
of B cells, which promotes humoral responses (Iyer and Cheng, 2012; Kriek, Areda and 
Didaba, 2019). As African elephants are known to display strong humoral responses to TB 
(Lyashchenko et al., 2006, 2012; Greenwald et al., 2009), IL10 may play an important role in 
the shift towards a humoral response. During inflammation, IL10 inhibits the production of 
pro-inflammatory cytokines TNFα and IFNγ, to down-regulate the immune response and 
prevent tissue damage (Ouyang et al., 2011; Redford, Murray and O’Garra, 2011; Ramani et 
al., 2015). As TNF expression was also up-regulated following 24 hours of mitogen 
stimulation, the high level of IL10 expression may be an antagonistic response to control 
inflammation. 
Like IL10, the anti-inflammatory cytokine TGFβ plays a role in down-regulating immune 
responses to pathogens, and helps with tissue repair (Ramani et al., 2015). Although TGFβ is 




been shown to have both proapoptotic and antiapoptotic effects (Howe, 2003). In this study, 
slight down-regulation of TGFβ expression was observed at 6 hours, while the median 
expression at 24 hours indicated no immune activation or a short-lived immune response, with 
a fold change of 1. This down-regulation of TGFβ could be mediated by the immune system to 
prevent suppression of T-cell responses and macrophage deactivation (Toossi and Ellner, 
1998). As TGFβ is also known to induce IL10 expression, the low level of TGFβ and the high 
level of IL10 could indicate a shift in the inflammatory response. 
The observations of up-regulation for IL10 and down-regulation of TNF and TGFβ 
expression in mitogen stimulated African elephant blood were comparable with immune 
responses observed in unstimulated whole blood from Asian elephants (Landolfi et al., 2010). 
Possible explanations for this could be suboptimal immune activation at these time points, or 
suboptimal induction of immune responses by PWM. In our study, PWM was the selected 
mitogen as it was previously shown to induce IFNγ in whole blood cultures of African 
elephants (Angkawanish et al., 2013; Songthammanuphap et al., 2020). Future studies should 
investigate the use of other mitogens such as Concanavalin A (ConA), phorbol myristate 
acetate plus ionomycin (PMA/I) or phytohaemagglutinin (PHA) which has been shown to 
induce IFNγ production in elephant PBMC cultures (Angkawanish et al., 2013; Landolfi et al., 
2014; Songthammanuphap et al., 2020). Another explanation could be that these cytokines do 
not play an important role in immune responses in elephants. Thus, further investigation into 
the role of these genes in the African elephant immune system is required and no definitive 
conclusions can be drawn regarding gene expression in this species. Finally, although gene 
expression was used as an indication of cell viability, future studies should consider using 
trypan blue exclusion assays to determine cell viability (Landolfi et al., 2014). 
Since the goal of this project was to develop cytokine GEAs as a step toward a diagnostic 
assay for TB in African elephants, samples were collected from animals in a M. bovis endemic 
park to explore the proof of concept that these assays could differentiate between MTBC 
immune sensitized and uninfected individuals. However, samples from only one suspect 
immune sensitized African elephant (based on negative mycobacterial culture and positive 
serological responses) were available. Since this elephant had antigen-specific cytokine 
responses comparable with those of the uninfected elephants, it was subsequently analyzed as 
part of the uninfected cohort. The low level of IL10, TGFβ and TNF expression in the suspect 
sensitized elephant may be indicative of an early infection, with CMI responses not yet being 




early humoral response, which may also influence the levels of gene expression observed in 
this elephant (Greenwald et al., 2009; Miller et al., 2018). Even though none of the elephants 
were confirmed to be MTBC immune sensitized, there was a high level of IL10 expression in 
response to stimulation with antigens PPDa and PPDb in several individual elephants, which 
demonstrates that cytokine responses can be detected in antigen-stimulated elephant blood 
samples. However, this up-regulation was likely due to cross-reactivity with environmental 
mycobacteria that share antigens with MTBC (Borsuk et al., 2009; Cho et al., 2012). Overall, 
the negligible change in cytokine expression in cells stimulated with specific mycobacterial 
peptides (QFT-TB2) was expected in uninfected elephants.  
In Asian elephants, no statistically significant difference in TGFβ expression was observed 
between TB seropositive and seronegative cohorts following antigen stimulation of PBMC 
cultures (Landolfi et al., 2014). However, higher levels of TNFα expression were measured in 
unstimulated peripheral whole blood samples (Landolfi et al., 2010); as well as mRNA 
extracted from antigen stimulated PMBCs of seropositive versus seronegative Asian elephants. 
Although not significant, baseline expression of TNFα, IFNγ, and IL4 tended to be higher, and 
TGF, IL10, and IL12 lower in the TB seropositive Asian elephants (Landolfi et al., 2010). 
Further studies should investigate responses in known immune sensitized/infected elephants to 
identify cytokines that can be used as biomarkers for TB. 
There were several limitations encountered in this study. Since elephant samples were 
collected opportunistically from immobilized animals, the number of samples and conditions 
for processing were determined prior to the initiation of the project. A limited number of 
African elephants were used for sequencing of mRNA transcripts (n = 2), as well as the 
measurement of temporal immune responses to PWM stimulation (n = 3). During the 
development of the real-time RT-qPCRs, the unsuccessful amplification of IFNγ, CXCL9, 
CXCL10, inefficient amplification of IL12, and the non-compatibility of IL4 with GAPDH may 
be a result of flaws in primer design or lack of optimization of PCR conditions. In addition, the 
selection of PWM as the mitogen may not be ideal for immune activation of African elephant 
whole blood. The absence of a MTBC culture confirmed infected African elephant prevented 
assessment of antigen-specific cytokine gene expression for identification of candidate 
biomarkers for TB detection. Thus, future studies will need to investigate the use of IL10, TNF, 
and TGFβ, using confirmed infected and uninfected African elephants, to determine optimal 
incubation time points, mitogen selection, additional cytokine genes, to assess whether these 




Chapter 5: General Conclusion 
In this chapter, the overall contributions of this study’s findings to the understanding of immune 
responses in African elephants are highlighted. Recommendations for future research are also 
included.  
 
The characterization of immune responses is important to understanding factors that affect 
the health and welfare of African elephants, and thus their conservation. Knowledge of and 
tools to assess immune responses can facilitate diagnosis and strategies for disease 
management. Since there is a paucity of information on the African elephant immune system, 
this study aimed to identify biomarkers of immune activation, as well as immune sensitization 
to MTBC infection, as a first step towards development of diagnostic tools to improve disease 
detection and surveillance. 
To our knowledge, this is the first study to investigate cytokine responses in African 
elephants using mRNA extracted from stimulated whole blood. During this study, Asian 
elephant and common warthog primers were modified to successfully amplify the first 
confirmed cytokine and reference gene mRNA transcripts for African elephants. The resulting 
transcripts contained full and partial coding sequences and showed high identity to Asian 
elephant (96.6-99.8%) and common warthog (72-97.6%) mRNA transcripts for these 
cytokines. Future studies should consider the use of reagents designed for Asian elephant and 
other species to detect immune responses in African elephants. The generated African elephant 
transcripts facilitated the design of species-specific primers for RT-qPCR amplification, and 
the development of real-time RT-qPCRs for IL10, TGFβ, and TNF. These RT-qPCRs will 
provide an important foundation for development of future assays in this species as well as 
studies on comparative immunobiology. 
Findings from this study demonstrated that cytokine gene expression assays show promise 
for detecting immune activation in African elephant whole blood. However, only three target 
genes (IL10, TGFβ, and TNF) and the reference gene GAPDH, were determined to meet the 
criteria for the development of the GEA. Although other African elephant cytokine and 
reference genes were sequenced, additional optimization will be required to develop a more 
robust panel of GEAs and identify biomarkers for detection of antigen-specific immune 




Cytokine expression in mycobacterial antigen stimulated African elephant samples revealed 
up-regulation of IL10 in response to complex mixtures of purified protein derivative from M. 
avium and M. bovis, suggesting that these elephants were sensitized to environmental antigens. 
However, since none of the elephants were known to be infected with MTBC, it was not 
possible to determine if these GEAs could distinguish between African elephants that were 
immune sensitized or not.  
The GEAs developed in this study included both pro-inflammatory and anti-inflammatory 
cytokines which have been associated with detection of and immunity to MTBC infection. The 
balance of TH1 (cell-mediated) and TH2 (humoral) responses is important in determining 
outcome, although cytokine profiles can vary by species (Rhodes et al., 2000, 2011; Thacker, 
Palmer and Waters, 2006; Cavalcanti et al., 2012). Since elephants show a robust humoral 
response to TB (Greenwald et al., 2009), it would not be unexpected that they also have a 
unique cytokine profile. Therefore, further investigation of cytokine gene expression in African 
elephants may provide insight into their immunologic response patterns, which could inform 
novel diagnostic tests. 
Findings in this project as well as other recent studies have shown that use of reagents and 
assays developed for other species, such as cytokine primers and ELISA antibodies, can be 
adapted for use with elephant blood (Landolfi et al., 2009; Edwards et al., 2020). Therefore, 
this may provide a more efficient approach to studying immune responses in these species. For 
example, the Equine RT2 Profiler PCR array (Qiagen) has been used to screen RNA extracted 
from QuantiFERON® TB Gold Plus (In-Tube) (QFT; Qiagen) stimulated whole blood from M. 
bovis-infected white rhinoceros to identify candidate biomarkers for TB (Chileshe et al., 2021). 
A similar study using either RNA or plasma from QFT stimulated elephant whole blood could 
be performed for biomarker discovery. This would significantly advance insight into the 
elephant immune system and comparative immunobiology of responses to TB.  
Future studies should be designed to address the limitations of this study and use findings 
to advance knowledge of the role of cytokines in African elephant immune responses. Larger 
sample sizes are needed to confirm cytokine sequences and investigate possible SNPs between 
African elephant transcripts. The investigation of temporal responses should also include a 
larger study population, ideally including samples from trained elephants to determine the 
influence of stress on immune responses. Identification of known MTBC infected elephants 




Collaborations established during this study, between local and international researchers, as 
well as governmental and private organizations (SANParks, SANBI-NZG, State Veterinarians 
from DALRRD, and veterinarians at private wildlife reserves), can potentially provide access 
to diverse African elephant populations. Finally, other aspects, such as antibody responses 
should be investigated for complete understanding of immune responses in this species and 
increase knowledge of TB responses. The cytokine GEAs developed in this study are the first 
step in identifying biomarkers that could be assessed using cytokine release in plasma from 
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Figure 1: Amplification curves and derivative melt peaks (DM) of GAPDH (A), IL10 (B), TGFβ (C) and TNF (D) following amplification of a 
five-fold serial dilution, with an estimated cDNA range of 1000 to 0.064 ng. Each dilution point was run in triplicate (indicated in green) and 
amplification efficiency (E) determined as previously described. No-template controls are indicated in green. The derivative melt peak (M) 






Figure 1 (Continued): Amplification curves and derivative melt peaks (DM) of GAPDH (A), IL10 (B), TGFβ (C) and TNF (D) following 
amplification of a five-fold serial dilution, with an estimated cDNA range of 1000 to 0.064 ng. Each dilution point was run in triplicate (indicated 
in green) and amplification efficiency (E) determined as previously described. No-template controls are indicated in green. The derivative melt 




   
  
Figure 2: Standard curves of GAPDH (A), IL10 (B), TGFβ (C) and TNF (D) used to determine amplification efficiencies (E) as previously described 
(Livak and Schmittgen, 2001), following amplification of a five-fold serial dilution, with an estimated cDNA range of 1000 to 0.064 ng. 





Figure 3: Expression stability of candidate reference genes as calculated using the geNorm 
applet in Microsoft Excel (Vandesompele et al., 2002) and the NormFinder Excel Add-In 
(Andersen, Jensen and Ørntoft, 2004). Whole blood from three African elephants stimulated 
with PBS and 10 μg/mL was used to determine stability values.  
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